Next Article in Journal
Children and Adolescents in the United States with Usual High Added Sugars Intake: Characteristics, Eating Occasions, and Top Sources, 2015–2018
Previous Article in Journal
Gut Microbial-Derived Short Chain Fatty Acids: Impact on Adipose Tissue Physiology
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Immune System and Epidemics: The Role of African Indigenous Bioactive Substances

by
Chiara Frazzoli
1,
Gerardo Grasso
2,
Danladi Chiroma Husaini
3,
Doris Nnenna Ajibo
4,
Fortune Chiemelie Orish
5 and
Orish E. Orisakwe
6,*
1
Department for Cardiovascular, Endocrine-Metabolic Diseases, and Aging, Istituto Superiore di Sanità, 00162 Rome, Italy
2
Istituto per lo Studio dei Materiali Nanostrutturati Sede Sapienza, Consiglio Nazionale delle Ricerche, P.le Aldo Moro 5, 00185 Rome, Italy
3
Department of Pharmacology & Toxicology, Faculty of Health Sciences, University of Belize, Belmopan P.O. Box 430, Belize
4
Department of Experimental Pharmacology & Toxicology, Faculty of Pharmacy, University of Port-Harcourt, Port-Harcourt 5323, Nigeria
5
Provictoire Research Institute, Port-Harcourt 234, Nigeria
6
African Centre of Excellence for Public Health and Toxicological Research (ACE-PUTOR), University of Port Harcourt, PMB, Port Harcourt 5323, Nigeria
*
Author to whom correspondence should be addressed.
Nutrients 2023, 15(2), 273; https://doi.org/10.3390/nu15020273
Submission received: 10 December 2022 / Revised: 28 December 2022 / Accepted: 29 December 2022 / Published: 5 January 2023
(This article belongs to the Section Nutritional Immunology)

Abstract

:
With over 6 million coronavirus pandemic deaths, the African continent reported the lowest death rate despite having a high disease burden. The African community’s resilience to the pandemic has been attributed to climate and weather conditions, herd immunity, repeated exposure to infectious organisms that help stimulate the immune system, and a disproportionately large youth population. In addition, functional foods, herbal remedies, and dietary supplements contain micronutrients and bioactive compounds that can help boost the immune system. This review identified significant traditional fermented foods and herbal remedies available within the African continent with the potential to boost the immune system in epidemics and pandemics. Methodology: Databases, such as PubMed, the Web of Science, and Scopus, were searched using relevant search terms to identify traditional African fermented foods and medicinal plants with immune-boosting or antiviral capabilities. Cereal-based fermented foods, meat-, and fish-based fermented foods, and dairy-based fermented foods containing antioxidants, immunomodulatory effects, probiotics, vitamins, and peptides were identified and discussed. In addition, nine herbal remedies and spices belonging to eight plant families have antioxidant, immunomodulatory, anti-inflammatory, neuroprotective, hepatoprotective, cardioprotective, and antiviral properties. Peptides, flavonoids, alkaloids, sterols, ascorbic acid, minerals, vitamins, and saponins are some of the bioactive compounds in the remedies. Bioactive compounds in food and plants significantly support the immune system and help increase resistance against infectious diseases. The variety of food and medicinal plants found on the African continent could play an essential role in providing community resilience against infectious diseases during epidemics and pandemics. The African continent should investigate nutritional, herbal, and environmental factors that support healthy living and longevity.

1. Introduction

The coronavirus pandemic recorded a high incidence of infections, hospitalizations, and deaths globally. As of May 2022, over 6 million people have died due to the coronavirus infection worldwide, with the African continent accounting for less than a million deaths, making the continent have the lowest death count due to the COVID-19 pandemic [1]. Approximately 25% of the global disease burden had been reported in Africa before the coronavirus. An estimated 2.4 trillion USD is spent annually in the region due to a high prevalence of communicable and non-communicable diseases, injuries, and trauma [2]. In addition, lack of resources, absence or inadequate modern health facilities, lack of access to health facilities, corruption and bad governance, harmful cultural practices, and environmental factors added to the challenges of sustainable health development in the continent [3,4]. Despite these overwhelming disease challenges in Africa, a lower prevalence of COVID-19 deaths was reported. Climate and weather conditions, herd immunity, repeated exposure to infectious organisms that help stimulate the immune system, and a disproportionately large youth population have been put forward as possible reasons for the lower death rates of COVID-19 [5]. Furthermore, due to the fear of acquiring COVID-19, African healthcare workers occasionally forsook their posts, leaving some to die from other diseases, such as stroke, diabetes, cardiovascular diseases, and malaria, as they had no easy access to therapy. Thus, a proportion of the excess deaths during the pandemic were not directly connected to COVID-19 but partly to medical negligence and mismanagement [5].
In addition, the disease prevention of various types of disorders, such as cardiovascular diseases, obesity, and infectious diseases, has been appropriately linked to correct eating habits, adequate diet, and exercise [6]. The efficient performance of the immune system is fundamental to the prevention and sustenance of the body; hence, good nutrition derived from food components is fundamental in boosting the immune system. Functional foods, herbal remedies, and dietary supplements contain micronutrients and bioactive compounds that can help boost the immune system. Micronutrients and bioactive natural substances can boost communities’ resilience to contagious epidemics in Africa and around the world. Micronutrients in foods, plants, and dietary supplements are widely acceptable, available, affordable, and accessible by the general population in Africa. Furthermore, micronutrients in food and plants contain antioxidant, anti-inflammatory, cardioprotective, and immunomodulatory activities that might have contributed to the lower rates of deaths reported on the African continent due to COVID-19. Therefore, foods, food ingredients, and plants are significant in preventing and treating infections during pandemics and their health outcomes. Undoubtedly, in addition to good nutritional diets, hygiene practices and vaccinations are still the most effective recommended public health measures against all viral infections [7]. We conducted this review to identify significant African traditional fermented foods and herbal remedies that are acceptable, available, affordable, and accessible with the potential for use in epidemics and pandemics. We presented their traditional uses, active ingredients, pharmacologic activity, and potential for providing community resilience during epidemics and pandemics. The review is intended to motivate the exploitation of health benefits from traditional African fermented foods and bioactive compounds found in medicinal plants for future epidemics and pandemics, taking into consideration the general population, subgroups, and regional variations within the African subcontinent.

2. Literature Search Methodology

We searched PubMed, Web of Science, Scopus, JSTOR, Google Scholar, and ScienceDirect databases to identify peer-reviewed research, books, review articles, and articles that examined traditional fermented foods and herbal remedies used in epidemics and pandemics within the African continent. Articles and publications that evaluated “fermented foods as immune boosters,” “fermented cereal,” fermented meat,” “fermented fish,” “fermented dairy products,” “immune boosters,” “pandemics,” “epidemics,” and “treatment of viral infections,” “micronutrients,” “bioactive compounds,” “prevention of disease,” “community health resilience,” “herbal remedies,” “medicinal plants,” traditional nutritional supplements,” “nutritional foods,” and “disease management.” All accessed articles published were prioritized as editorials, news articles, and WHO publications considered relevant to the review. The search scope included all the countries on the African continent. The authors conducted the literature search between June 2021 and April 2022.

3. Results

3.1. African Traditional Fermented Foods

3.1.1. Cereal-Based Fermented Foods

Cereals are staple foods in Africa. The most commonly used cereals include maize (Zea mays), sorghum (Sorghum bicolor), millet (Peninsetum americanum), and acha or fonio (Digitaria exilis). These cereals are characterized by a high content of soluble non-starch polysaccharides (e.g., arabinoxylan and β–glucan), which have a health-promoting role and rich nondigestible carbohydrates (e.g., galacto- and fructooligosaccharides), excellent substrates for fermenting micro-organisms [8]. In sub-Saharan Africa, cassava (Manihot esculenta), also known by several regional names, is mainly a smallholder root crop, crucial for the food security of smallholder farmers, and primarily used to produce traditional fermented foods [9].
Fermentation of cereals is a common food processing practice performed at the household level for cereal preservation. It plays a crucial role in attaining food and nutrition security in sub-Saharan Africa [10]. Generally, fermentation positively affects the antioxidant activity of fermented grain-based foods through increased phenolic compounds, gamma-aminobutyric acid (GABA), and bioactive peptides. Changes in the vitamin contents of cereals due to fermentation vary according to the process conditions and the raw material used [11]. An increase in folate content is debated, and there is a current lack of information and research about the effect of lactic acid bacteria (LAB)-mediated fermentation on the vitamin content in fermented cereal foods [12]. Folate deficiency can cause severe deficiency during pregnancy, and there is evidence that insufficient intake of folic acid and cobalamin (vitamin B12) can drastically alter the immune system’s balance [13]. Saubade et al. (2018) [14] observed a relatively low folate content in ben-saalga, a pearl-millet-based fermented porridge from Burkina Faso, suggesting that folate is lost during the different processing steps. The step of spontaneous fermentation had no significant impact on folate content. Processing methods from different raw materials using corn, sorghum, and pearl millet have been shown to affect folate content and bioaccessibility in ben-saalga and six other African cereal-based fermented foods (akassa, doncounou, kaffafura, massa, and ben-kida). The main factors involved are the starting raw materials and traditional processing steps. Folate bioaccessibility is very variable and strongly influenced by the food matrix structure. Although the fermentation process positively affects the folate content in kaffa and akassa, the folate content is relatively low [15]. The optimum conditions for folate biosynthesis by LAB are still unclear, and optimizations are required to increase the LAB-mediated folate production in fermented food products [16]. Bacteria belonging to the genera Lactobacillus, Lactococcus, Leuconostoc, and Pedicoccus have been associated with cereal-based fermented foods. Other micro-organisms may be involved in fermentation processes, such as yeast species of Saccharomyces, Rhodotorula, Candida, Kluyveromyces, and Geotrichum genera [17], as well as filamentous molds belonging to the genera Aspergillus, Rhizopus, Fusarium, and Penicillium [8,18].
Pedersen et al. (2012) have identified C. krusei and K. marxianus as the dominant yeast species involved in the fermentation of fura, a spontaneously fermented pearl millet product consumed in West Africa. Both yeast species were capable of survival and growth under simulated gastrointestinal conditions and the transepithelial electrical resistance (TEER) of the human Caco-2 cell line, suggesting a potential probiotic property of these yeasts [19]. Owusu-Kwarteng et al. (2015) [20] obtained similar results, reporting the in vitro probiotic properties of sixteen Lactobacillus fermentum strains isolated from West African fermented millet dough. Interestingly, four L. fermentum strains showed antibacterial activity against Listeria monocytogenes NCTC 10527 and Staphylococcus aureus ATCC 1448. The yeast Pichia kudriavzevii strain isolated from ogi (a traditional, spontaneously maize-based fermented food from Benin) increased the production of folate (vitamin B9) when inoculated in pearl millet (Pennisetum glaucum)-based gruel with L. fermentum [21]. Yeast strains of K. marxianus and S. cerevisiae isolated from West Africa fermented dairy foods lait caillé and nunu and a cereal-based food mawè exhibited the highest probiotic potential [22]. Imade et al. (2021) [23] isolated four LAB strains identified as Limosilactobacillus fermentum NBRC15885, Limosilactobacillus fermentum CIP102980, Companilactobacillus nantensis LP33, and Lactiplantibacillus garii JCM1149 and isolated from fufu, nono, ogi, and kunu showed the ability to synthesize bacteriocin actives against pathogenic strains of B. cereus, Klebsiella pneumonia, and S. typhimurium. Bacteriocin is a ribosomally synthesized antimicrobial peptide that can exert a bioprotective effect against many food-spoilage and food-borne pathogenic bacteria, such as Staphylococcus aureus, Listeria monocytogenes, Bacillus cereus, and Clostridium botulinum [24].
Cereal-based fermented beverages are prevalent in Africa, and fermented food beverages are a rich source of bioactive compounds [25]. In Ethiopia, there is a long oral tradition about indigenous fermented beverages produced from different cereal raw materials, such as barley, maize, wheat, and honey. These beverages are mainly produced by acid and alcoholic fermentation (i.e., mediated by mixed cultures of micro-organisms, such as LAB and yeasts) [26,27]. Togwa (from maize flour, finger millet malt, Tanzania), a sweet and sour, nonalcoholic beverage, is one of the better-studied African cereal beverages. A different maize-based laboratory model of togwa showed how yeasts isolated from Tanzanian fermented food togwa can significantly increase folate content in the fermented product [28]. The yeast Pichia kudriavzevii isolates also showed potential probiotic abilities [21].
Several authors have described the potential role of food fermentation processes in reducing toxic compounds in raw food materials by harnessing autochthonous microflora involved in traditional fermentation processes or by adding selected starter cultures and adopting controlled fermentation. While few studies have documented an increase in mycotoxin levels after food fermentation processes, a decrease in mycotoxin levels has been generally reported [29]. In particular, the role of probiotics in mycotoxin biodetoxification has been described. Several micro-organisms have been reported to reduce mycotoxin accessibility, adsorption, and biotransformation in the gut through different mechanisms, including Lactobacillus, Bifidobacterium, and some Bacillus species of yeast Saccharomyces cerevisiae [30].
If fermentation processes seem to reduce mycotoxins levels in the final product (compared to the raw materials), traditionally processed beverages should benefit from adopting a value chain approach. Such an approach should include practical solutions to reduce mycotoxin exposure, such as educational interventions and grain-cleaning methods to optimize processing conditions/steps [31]. Recently, Nafuka et al. (2019) [32] highlighted the importance of monitoring emerging mycotoxins, aflatoxin precursors, and ergot alkaloids in sorghum malts used to produce Namibian traditional fermented sorghum-based beverages, omalodu and otombo. Indeed, the growth of mycotoxigenic fungi can be stimulated under warm, moist, and likely unhygienic conditions that may occur during the malting and milling processes.
The LAB and yeasts can also reduce exposure to various chemical food contaminants, including metals, metalloids, and cyanotoxins [33]. The content of cyanogenic glycosides lotaustralin and linamarin is reduced in African-fermented cassava products, such as gari and fufu, during cassava fermentation by Lactobacillus, Streptococcus, and Leuconostoc [34]. The LAB potentially detoxify heavy metals in foods through biosorption, bioaccumulation, and transformation [35]. The detoxification of heavy metals further enhances the potential probiotic relevance of LAB, many of which are found in several Nigerian fermented foods [36].

3.1.2. Meat- and Fish-Based Fermented Foods

Numerous meat-based fermented foods are also present in many traditional African diets, especially in the Mediterranean [37]. Together with dairy products, fermented meat products are also sources of peptides with antioxidant activity [11]. Recent studies have focused on the identification and quantification of bioactive peptides derived from fermented meat products and their possible roles in disease prevention [38].
Several studies have reported microbiological characterizations of fermented meat products from North Africa. For instance, Belgacem et al. (2010) [39] isolated 24 strains of Enterococcus faecium from gueddid, a traditionally Tunisian fermented meat, producing bacteriocin production with inhibitory activity against Listeria spp., Enterococcus spp., and Staphylococcus aureus. One isolate was active against Escherichia coli CECT 877. Nine of the antagonistic enterococci tested did not show any virulence traits or produce biogenic amines. Despite the probiotic potential of the genus Enterococcus, as well as their contribution to the ripening and aroma development of fermented meat products, the prevalence of virulence factors and antibiotic-resistance genes and their ability to cause disease can pose risks for food safety issues [40]. Thus, to properly evaluate food safety in traditional fermented meat productions, the monitoring of Enterococcus strains should be encouraged.
Boudechicha et al. (2017) [41] provided a preliminary microbiological characterization of khliaa ezir, Algeria’s traditional cured meat product. The LAB are the most bountiful in the product during the ripening and storage. A low level of enterobacterial population and a high general hygiene quality have been attributed to the spicing and salting thermal treatment steps. Similar results have been obtained by Benlacheheb et al. (2019) from a microbiological study on el-guedid, an Algerian traditional fermented red meat-based product [42]. Aerococcus and Enterococcus species isolated from el-guedid have exhibited a probiotic potential [43]. Bader et al. (2021) reported the results of a more comprehensive study of el-guided physicochemical and microbiological properties, considering the type of raw red meat and the conservation time [44]. Lactic acid bacteria and coagulase-negative staphylococci were the dominant populations in el-guedid, including Leuconostoc mesenteroides, Lactobacillus sakei, and Staphylococcus saprophyticus. In particular, L. sakei and L. mesenteroides can produce bacteriocins that could contribute to the microbiological safety of el-guedid. Bacteria, including LAB and coagulase-negative staphylococci, can increase the safety of fermented meat products by controlling or reducing the microbiological hazards of bacteriocin production [45]. Generally, bacteriocins have shown a tremendous inhibitory effect on Listeria monocytogenes in meat products [46]. Bacteriocin production could have a protective culture in fermented meats for the control or reduction in microbiological hazards; however, bacteriocins may inhibit desired starter cultures and may not be active against food spoilage bacteria [47].
Fermentation is also a widespread practice for fish preservation in Africa. Prominent examples are lanhouin (Benin and Togo), momone, koobi, kako, and ewule (Ghana), guedj (Gambia), tambadiang, and guedj (Senegal), djege and jalan (Mali), fessiekh, kejeick, terkeen, and mindeshi (Sudan), dagaa (Uganda), gyagawere, adjonfa, and adjuevan (Côte d’Ivoire), and salanga (Chad) [48]. In local cereal-based diets, fermented fish products are generally used as taste- and flavor-enhancing condiments or as a source of animal proteins. The production of traditional fish-based fermented foods is based chiefly on spontaneous fermentation processes. As for many other traditional food fermentations, such food processing techniques would require more attention both in terms of standardization of the operations and improvement in hygienic aspects [49,50,51]. The LAB and yeasts are the dominant micro-organisms in many fermented fish products [52]. Many yeast and bacterial strains have been isolated from momoni, a Ghanaian fermented fish condiment, with Bacillus species predominant [53]. However, authors have suggested that the fermentation process is mediated by the endogenous fish enzymes rather than the associated microflora due to the high pH and high salt concentrations. Farag et al. (2022) have suggested that future studies will be required to understand the better microbial impact on the quality of fermented and salted fish such as feseekh, moloha, and renga from Egypt [54].
Lanhouin is a fermented fish-based product widely used as a condiment in Benin, Togo, and Ghana. Lanhouin is processed by spontaneous fermentation from different fishes, such as cassava croaker/cassava fish (Speudotolithus sp.) or Spanish mackerel/kingfish (Scomberomorus tritor), and different processes as well. Anihouvi at al. (2007) [55] have reported changes in microbial communities during spontaneous fermentation of lanhouin from cassava fish (Pseudotolithus sp.). Bacillus subtilis, Bacillus licheniformis, Staphylococcus lentus, and Staphylococcus xylosus persisted up to the end of fermentation.
Koffi-Nevry et al. (2011) [56] have studied the LAB communities in adjuevan, a traditional salted fermented fish (the Atlantic bumper, Chloroscombrus chrysurus) from Côte d’Ivoire. Lactobacillus fermentum, Leuconostoc lactis, Pediococcus sp., and Streptococcus sp. have been isolated both from the fresh fish Chloroscombrus chrysurus and the adjuvant samples. Similarly, adjuvant microbial community dynamics were produced using the whole fish and fish fillets [57]. Although the composition varied according to the preparation method, yeast, and several LAB communities were found for both. LAB included Lactobacillus, Pedicoccus, Lactococcus, Streptococcus, and Leuconostoc species, but no LAB species were dominant. Clémentine et al. (2020) [58] have instead studied yeast diversity in adjuevan fermentation. Seven species of yeast have been identified, and varied fermentation methods and salt concentrations used. These include Pichia fermentans, Candida zeylanoides, Candida sp., Hanseniaspora osmophila, Kluyveromyces sp., Torulaspora delbrueckii, and Kluyveromyces marxianus. All these yeast species have probiotic potential [59].

3.1.3. Dairy Fermented Products

With its substantial social and cultural value, milk has always been a critical dietary component in sub-Saharan pastoral communities [60,61].
As for other fermented foods, fermentation was primarily used as a traditional food preservation practice for surplus milk produced during the wet season. Regarding their health-promoting properties, yogurt and fermented milk have higher antioxidant activity than milk because of the release of bioactive peptides by microbial-mediated proteolysis. Dairy products are rich sources of bioactive peptides with several activities, including immunomodulatory and antioxidant properties [38]. Several factors can influence the antioxidant power of fermented milk, such as milk origin, milk fat content, and the presence and position in milk peptides of the amino acids tryptophan, tyrosine, methionine, and fermenting micro-organism strains [62]. Increased formation of conjugated linoleic acid (CLA) and folates in fermented milk can also increase antioxidant power [11]. Dairy products are excellent sources of vitamin B12, mainly synthesized by anaerobic micro-organisms [63]. Another vitamin essential for human health is the lipid-soluble vitamin K. In particular, one of the two biologically active forms of vitamin K, vitamin K2, is predominantly of microbial origin and refers to a group of menaquinones (MKs) with different side chain lengths. Long-chain vitamin K2 forms are produced by food-grade bacteria involved in food fermentation processes, such as Bacillus subtilis and, interestingly, by some species and strains of LAB, such as Lactococcus lactis ssp. Cremoris, L. lactis ssp. Lactis, Leuconostoc lactis, and Leuconostoc mesenteroides [64]. Vitamin K2 can also be synthesized by bacteria belonging to the Bacteroides genus, one of the two most important gut microbiota genera. However, due to its poor bioavailability, the major source of functionally available vitamin K2 is the diet. Therefore, dairy products may be a predominant source of dietary MK in many regions of the world. Recently, there has been considerable interest in enhancing the MK content of dairy products through the identification and selection of MK-producing bacteria in dairy fermentations [65].
Fermented milk is the most widely fermented dairy product in traditional African diets. Some examples include spontaneously fermented milk, such as iben (Algeria, North Africa), sussa (Ethiopia, Somalia, Kenya, and Sudan), ergo (Ethiopia), kule and amabere amaruranu (Kenya), kivuguto (Rwanda), amasi (Zimbabwe), and nunu (Ghana). Inoculated fermentation methods, in some cases performed as semicontinuous or fed-batch fermentation processes, are also practiced. Even if not properly standardized, such inoculated fermentation methods can contribute to the stabilization of production processes. Some examples include zabady (Egypt), rob, biruni, garris (Sudan), masse (Mozambique), madila (Botswana), and omashikwa (Namibia). The preparation of fresh and ripened cheeses is also part of traditional diets [66].
The LAB, such as Lactococcus lactis, Streptococcus infantarius subsp. Infantarius and Lactobacillus spp. dominate African fermented dairy productions mainly as autochthonous milk microflora and indigenous microbial flora, brought by utensils and containers used for milk preservation [67]. Mesophilic bacteria (Lactococcus and Leuconostoc spp.) in fermented dairy foods are found mainly in cold climatic regions, while thermophilic bacteria (Lactobacillus and Streptococcus spp.) are found in hot climatic regions. Yeasts are often associated with fermented dairy products, e.g., amabere amaruranu, gariss, nunu, and rob [68]. Lack of standardization procedures and scarce hygiene conditions that often occur in milk production and processing can affect fermented dairy products’ shelf stability and pose risks to consumers [69,70,71,72]. A recent review about pathogenic and chemical contaminants in dairy products across sub-Saharan Africa highlighted current gaps as well as the need for robust investigations into these food safety risks [73].
The LAB present in dairy fermented products can exert bioprotection against food spoilage and food-borne pathogenic bacteria (e.g., Staphylococcus aureus, Escherichia coli, Campylobacter jejuni, and Vibrio cholera), mainly through a pH reduction that occurs during fermentation. Todorov (2008) [74] reported the production of bacteriocins active against Listeria, produced by Lactobacillus Plantarum isolated from amasi (a naturally fermented milk product from Zimbabwe). Moshba et al. (2018) have reported the production of bioactive peptides from the proteolysis of whey proteins in camel milk with antimicrobial activity against S. aureus, P. aeruginosa, K. pneumoniae, and E. coli [75]. The inhibitory effect of camel milk against pathogenic micro-organisms is well known [76]. In addition, several bioactive compounds (lactoferrin, α-lactalbumin, β-caseins and vitamin C, lysozyme, IgG and secretory IgA, and insulin-like protein) present in camel milk exhibited antioxidant, anti-inflammatory and immunomodulatory properties [77].
Rural dairy processing can also contribute to the protection of the final product against food-borne pathogenic bacteria. Two examples are the production of smoked vessels for the Ethiopian fermented milk ergo that can slow the growth of coliforms or the use of flavors, such as black cumin in mish, a ripened soft cheese from Egypt and Sudan [66]. Most artisanal cheeses in East Africa and Northern Africa are soft cheeses [78]. Some examples of fresh cheeses include klila, warankasi, kariesh (or karish), ayib, and gibna. In North Africa, hard-ripened cheeses (such as domiati, mish, and bouhezza) are more common than in other parts of Africa [66]. Some exceptions include touaregh (Mali) and tchoukou (Niger) [78]. Traditional cheese production at the rural level is generally characterized by scarce hygiene standards favored by a lack of cheese-making standardization in safety aspects managed empirically. Abdelfatah and Tahoun (2015) studied LAB in Kariesh cheese, and a variety of LAB have been isolated. In particular, Lactobacillus rhamnosus was the most prominent strain in kariesh cheese, and the high antibiotic-resistant Lactococcus garvieae pathogenic strain was isolated [79]. The probiotic potential of Pediococcus acidilactici isolated from wara has been recently investigated and reported [80]. Tchoukou cheese (Niger) is a rich source of calcium and zinc with high nutritional value [81]. A recent evaluation reported the probiotic potential of lactic acid bacteria strains isolated from tchoukou cheese [82]. The LAB Lactobacillus fermentum, Lactobacillus intestinalis, and Lactobacillus acidophilus isolated from klila cheese exhibited strong bactericidal activity against S. aureus [83].
Marino et al. 2012 [84] conducted a study to characterize healthy beneficial compounds in bouhezza cheese. Results showed how raw milk quality and cheese-making technology could strongly affect fat-soluble antioxidants, linolenic acid, and conjugated linoleic acid contents.
Results about traditional fermented foods with potential health benefits are presented in Table 1 and Figure 1.

3.2. Herbal Plants for Epidemics and Pandemics

In addition, nine herbal remedies and spices belonging to eight plant families have antioxidant, immunomodulatory, anti-inflammatory, neuroprotective, hepatoprotective, and cardioprotective abilities, with some having antiviral properties. Peptides, flavonoids, alkaloids, sterols, ascorbic acid, minerals, vitamins, and saponins are some of the bioactive compounds in herbal remedies.

3.2.1. Garcinia kola Heckel (Fam. Clusiaceae) [Bitter Cola]

Every part of bitter kola (Garcinia kola Heckel) is traditionally used in Africa to treat typhoid fever, bronchitis, bacterial infections, malignant tumors, skin infections, tuberculosis, gastritis, colds, and jaundice [85,86]. The plant is indigenous to Africa and pharmacologically evaluated in animal studies to have antiviral, antiasthma, antioxidant, antidiabetic, antihypertensive, antibacterial, antiasthma, and hepatoprotective activities [87,88,89]. Although G. kola has not been scientifically documented for use in pandemics, its traditional usage and bioactive constituents make the plant a candidate for use in pandemics and epidemics in Africa [85]. For instance, in recent reviews, G. kola has been suggested as a potential and promising medicinal plant for the treatment of coronaviruses due to its antiviral and antioxidant activities [90,91,92]. Similarly, G. kola, the active constituent of G. kola, has been reported to be active against polioviruses, measles virus, yellow fever virus, influenza, and herpes simplex virus-1 [93,94]. G. kola’s immunorestorative and immunomodulatory activities make it a significant plant in diseases causing immunodeficiencies, such as COVID-19 and AIDS [95]. The bioactive compounds found in G. kola include alkaloids, phenols, saponins, sterols, tannins, garciniflavanone, kolanone, garcinoic acid, kolaflavanone, and kolaviron [85,89,96]. The seed is also rich in phosphorous and potassium [96]. Kolavoviron has significant anti-inflammatory and antioxidant activity. It was reported to be effective against viruses via immunomodulating activities, metal chelating, and as a potent radical scavenger [93,97,98]. Furthermore, kolavoviron modulate oxidative stress via stimulation of phase 2 detoxification of enzymes, proving its chemopreventive effects. This action mitigates the expression of COX-2 and iNOS at the molecular level, downregulating AP-1 DNA and NF-kB binding, and mitigating oxidative damage to biomolecules [97,99,100]. Other derivatives of G. kola, such as guttiferones and garcinol, have been reported to inhibit the cytopathic effects of HIV [101]. Toxicological studies in rats and mice showed G. kola to be safe [102]. The long history of the seed’s usage and the safe toxicological profile make G. kola a suitable candidate for clinical trials in pandemics.

3.2.2. Artemisia afra Jacq. (Fam. Asteraceae) [African Wormwood]

Dihydroxybishopsolicepolide, scopoletin, acacetin, flavonoids, and yomogiartemin are the common phytochemicals identified and described in Artemisia [103,104]. The shrub is abundant in Northern, Eastern, and Southern Africa. It has been reported for use traditionally in treating influenza, respiratory infections, cough, malaria, diabetes, and fever [105]. The plant’s bioactive ingredients have been reported to have potent antioxidant activity through scavenging hydrogen peroxide and hydroxyl ions and modulating reactive oxygen species, thus, making Artemisia a protective agent that strengthens the antioxidant defense mechanism [106]. Furthermore, the phytochemicals in Artemisia and their derivatives provided selective cytotoxicity in randomized double-blinded subjects treated for colorectal cancer [107]. Slezakova and Ruda-Kucerova (2017) [108] further reported Artemisia’s promising potential in hepatocellular carcinoma, lung cancer, and breast cancer.
Artemisia also has significant antiviral activities against influenza virus A, human herpes viruses 1 and 2, hepatitis B and C, and HIV-1 viruses [109,110,111]. Artemisia’s general mechanism of action blocks the host-cell–type and metabolic requirements for viral replication by inhibiting the central regulatory activity of viral-infected cells [109,111,112].
Artemisia is an African indigenous traditional medicinal plant for treating diseases associated with pandemics and epidemics. Its antioxidant, anti-inflammatory, antiviral activities, low toxicity, and safety make Artemisia a potential drug candidate for the prevention and treatment of diseases in pandemics and epidemics on the continent of Africa [105,113].

3.2.3. Piper guineense (Fam. Piperaceae) [African Black Pepper]

One of the most valuable African plant species widely applied in traditional medicine is P. guineense. The plant has potent antioxidant properties with strong antibacterial, anticancer, and antiviral properties [114]. An ethnopharmacological survey showed that the plant is used in traditional African settings for sexually transmitted diseases [115]. Piperine, piperlongumine, ligans, monoterpenes, terpenoids, sterols, sesquiterpenes, and volatile oils are some of the bioactive compounds in P. guineense [116]. These alkaloids are scaffolds for discovering new drugs since they contain antimicrobial pharmacological properties [117,118]. For instance, piperine, a potent antibacterial agent, inhibits the efflux pump in Staphyloccocus aureus, making it a potential phytochemical for multidrug-resistant bacteria [119].
Furthermore, a recent study suggested that a combination of piperine and rifampicin improved rifampicin’s effectiveness, making piperine an agent that can reduce the adverse effects of rifampin when used in clinical therapy [120]. Apart from piper’s reported effectiveness as an anti-inflammatory and antiproliferative, the bioactive compound was also reported to demonstrate protection against chronic diseases based on clinical studies [110]. Furthermore, piperlongumine is effective as an anticancer, antifungal, antihelminth, and in treating many neglected tropical diseases in Africa, making P. guineense a valuable plant used in pandemics [110]. The effectiveness of piperlongumine in neurodegenerative diseases is due to its ability to inhibit or reduce the synthesis of prostaglandins E2, nitric oxide, cyclooxygenases-2, nuclear factor kappa B, interleukin-6, and tumor necrosis factor-alpha 9 [121,122]. Osho et al. (2016) reported the antiviral activity of P. guineense’s methanolic extract in broiler chickens infected with Newcastle disease virus (NDV) [123]. The numerous underlying mechanisms of action and multitargeting potentials of P. guineense are still being studied, even though the benefits have existed in Africa for a long time [122].

3.2.4. Achyranthes Aspera Linn. (Fam. Amaranthaceae)

The origin of Achyranthes aspera is in Africa, even though some literature indicates that the plant is also to be native to South Asia [124]. The plant has been associated with its usefulness in pandemics due to its significant antioxidant and immune-boosting abilities and its antiviral effects [124,125]. The antiviral potential of a methanolic extract of Achyranthes aspera was evaluated against herpes simplex virus type 1 and type 2. A. aspera demonstrated good anti-Herpes simplex virus activity [125]. In addition to its usefulness in pandemics, the entire part of A. aspera has been traditionally used in Africa and other parts of Asia for dysentery, arthritis, malaria, hemorrhoids, fever, pain, and diarrhea [124]. In addition, the plant is diuretic, anti-inflammatory, antiasthmatic, and valuable for pneumonia [126,127,128].
Triacontanol, eugenol, ecdysterone, and betaine are the main bioactive compounds in A. aspera. Furthermore, the plant’s antioxidant and immune-boosting activities are enhanced by ascorbic acid [128,129,130,131]. The ascorbic acid in A. aspera significantly boosts immunity and alleviates inflammation in the SARS-coronavirus by conferring antioxidant properties [92]. The chemopreventive effects of A. aspera have also been reported in a few studies. Saponin fractions of A. aspera considerably reduce early antigen activation elicited by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate in Raji cells by Epstein-Barr virus. [132]. Furthermore, A. aspera induced apoptosis through a mitochondrial-mediated pathway [133].

3.2.5. Allium sativum L. (Fam. Liliaceae) [Garlic]

Garlic (Allium sativum L., Fam. Liliaceae), though historically believed to originate from West China, is presently cultivated and used globally as a spice, immune booster, and a remedy during pandemics. Garlic is the first remedy to prevent and treat pandemics, such as influenza, typhus, cholera, and dysentery [134]. Garlic was fed to pyramid builders to boost immunity and was reported as a nutritional supplement in ancient inscriptions in Egyptian pyramid plates. In addition, garlic provided the builders with vitamins, balance, and the energy to pull the heavy plates used in building the pyramids [135].
Traditionally, garlic has been used in Africa to manage bacterial, parasitic, viral, and other infectious diseases [136,137,138]. Other uses included gynecological diseases, toothaches, snake bites, arthritis, and hypertension [136,137,139,140]. In general, garlic extracts are effective as antioxidants, anticancer, and antimicrobials and tend to reduce the risk of cardiovascular events [134,141,142]. Experimental animal and clinical studies have provided evidence of garlic’s effectiveness in managing the common flu, diabetes, hypertension, arthritis, and cancer prevention [142,143].
Over a hundred bioactive compounds are found in garlic, with allicin (thiosulfate) being the most active and responsible for garlic taste and smell [144]. Other sulfur-containing bioactive substances found in garlic include diallyl trisulfate, ajoenes, diallyl disulfide (sulfides), 2-vinyl-(4H)-1,3-dithiin, 3-vinyl-(4H)-1,2-dithiin (vinyldithiins), and alliin, which, constitutes majorly cysteine sulfoxide [145,146,147].
Garlic is used in pandemics due to its antioxidant, antiviral, and antibacterial activities [88]. Reduction in the synthesis of oxygen-free radical species has been reported with garlic when it is frequently consumed, promoting antioxidant activity [147,148]. Similarly, garlic extracts have been reported to reduce glutathione peroxides and superoxide dismutase in rats’ hepatic tissues [149,150]. In addition, high radical scavenging activity with different sulfur-containing substances in garlic, phenols, and flavonoids has been demonstrated with garlic extracts [151]. Other antioxidant activities of the bioactive compounds in garlic include a decrease in the synthesis of reactive nitrogen and oxygen species by diallyl sulfide through the enzymatic suppression of cytochrome P450-2E1, leading to hepatoprotection [147,152]; inhibition and H2O2-induced DNA damage with saponins extracted from garlic [153]; and the inhibition of NADPH oxidase 1 through the prevention of reactive oxygen species with alliin [154].
In a recent review, Batiha et al. (2020) [147] reported that garlic extract is effective against diverse viruses, such as vesicular stomatitis virus, human rhinovirus type 2, influenza virus type 3, human cytomegalovirus, influenza B type virus, and herpes simplex 1 and 2 [155]. The inhibition of adhesive interaction and fusion of leukocytes with ajoenes; inhibiting the synthesis of thiol enzymes by allicin; and the enhancement of natural killer-cell activity through the destruction of cells infected by viruses’ diallyl trisulfide on human cytomegalovirus are a few mechanisms of garlic’s action [147,155]. Finally, allicin has a wide range of activities against many bacterial organisms, including K. aerogenes, E. faecalis, S. enterica, E. coli, S. pyogenes, S. mutans, Mycobacteria, Shigella, P. vulgaris, and P. aeruginosa [137,149,156,157,158,159]. The ability of garlic to inhibit NF-kB and modulate cytokine expression makes it an immunomodulatory and effective plant for pandemics in Africa. Finally, prostaglandin-E2, COX-2, and nitric oxide production inhibition lead to a significant reduction in the synthesis of inflammatory interferon γ, interleukin-6, and TNF- α with garlic [159].

3.2.6. Moringa oleifera Lam. (Fam. Moringaceae)

Moringa oleifera is commonly called the miracle tree in Africa because of its numerous traditional and pharmacological activities against various diseases. The plant’s multipurpose nutritional and health benefits have been widely reported in Africa and most parts of the world [140,160,161,162]. The plant has been traditionally used in Africa for food, livestock feed, nutrition, and medicine [163]. Recently, Moringa has been used in biofuel production, cosmetics, and water purification [161,164]. The phytochemicals responsible for Moringa’s biological effects include isothiocyanate, phenolic acids, polyphenols, sterols, alkaloids, terpenes, flavonoids, and flavanol glycosides [160,161,162,163]. Some ethnopharmacological activities of moringa include antioxidant, parasitic diseases, antituberculosis, anticancer, antidiabetic, anti-inflammatory, sexually transmitted infections, typhoid fever, cardioprotective, neuroprotective, antihypertensive, and hepatoprotective effects [162]. Even though moringa significantly decreased triglyceride, cholesterol, and glucose levels in rats; the plant is safe and has a high therapeutic index [165]. Moringa leaves are rich in beta carotene, minerals, and proteins, essential compounds lacking in most populations found in developing nations. The ability of Moringa to boost the immune system and help the body fight infections has been reported. The plant showed some significant activities against various viruses, including HIV, and has been reported to be used in managing AIDS and diseases related to AIDS infections [166,167]. In addition, Moringa is effective against the influenza A virus, new castle disease virus, herpes simplex virus, Epstein-Barr virus, hepatitis B virus, and foot-and-mouth disease virus in cloven-footed animals [168]. Protection of infected host cells from cytopathic effect; decrease in the levels of cytokines; inhibition of the expression and nuclear transfer of cellular proteins transcription factor EB leading to a weakening of the autophagy infected cells; and the inhibition of viral replication in host cells are some of the reported antiviral mechanisms of action of moringa [169]. These biologic activities made Moringa an African medicinal plant used to prevent and treat pandemics and diseases related to pandemics in the African continent.

3.2.7. Zingiber officinale R. (Fam Zingiberaceae) [Ginger]

Zingiber officinale R. (Fam Zingiberaceae) is presently widely cultivated in most African countries for the prevention and treatment of common influenza, cough, sore throats, arthritis, lung diseases, peptic ulcer disease, hypertension, and infectious diseases, such as bacterial and viral infections. Although Ginger was initially used as a food spice and for medicinal plants in China, the use of ginger in Africa for the prevention and treatment of diseases has been documented [170]. Presently over 100 species of ginger are cultivated worldwide; however, Z. officinale is the most cultivated and used as an ingredient for food and medicinal plants [171,172].
The US Department of Agriculture (2013) identified steroids, phenols, and alkaloids as the bioactive compounds found in ginger with therapeutic activities. Other active compounds include gingerols, zingerone, zingiberol, paradols, and shogaols [173,174,175,176]. Ginger has been widely reported to have antiarthritic, anticancer, antioxidant, anti-rhinoviral, antimicrobial, and antiglycemic pharmacological activities [174,177,178]. Shogaol and gingerol have significant pharmacological activity compared to other bioactive compounds found in ginger [179].
Ginger’s antiviral, antioxidant, and antibacterial effects make it a viable medicinal herb and spice used to prevent and manage pandemics in Africa [180]. Chang et al. (2013) demonstrated that fresh ginger acts by blocking viral attachments and internalization and is effective against human respiratory syncytial virus-induced plaque formation on airway epithelium [181]. Similarly, Rathinavel et al. (2020) reported that 6-gingerol, a phytocompound from Z. officinale, showed high binding affinity against SARS COVID-19, including spike proteins, RNA binding, and viral proteases proving antiviral activity, making 6-gingerol a promising bioactive compound for COVID-19. Good ADME pharmacokinetic properties and excellent drug-likeness parameters with zero rule violations were demonstrated by 6-gingerol [182]. Generally, the Zingiberaceae plant family (Zingiber officinale, Curcuma longa, and Aframomum melegueta) is effective against a wide variety of viruses, such as Enterovirus 71, Japanese encephalitis virus, Epstein-Barr virus, Herpes simplex virus types 1 and 2, influenza A virus, human immunodeficiency viruses, coronavirus SARS-CoV-1, rhinovirus, chikungunya virus, and respiratory syncytial virus. In addition, these herbs are significant immune system boosters and excellent sources of nutrition [180].
Furthermore, besides possessing antiviral activities, Z. officinale has significant antioxidant activities. Zingerone, for instance, suppresses lipid peroxidation and scavenges hydroxyl ions and peroxides [183,184,185]. Similarly, 6-gingerol effectively protects against ultraviolet B-induced skin disorders in rats by inhibiting the induction of NF-kappa translocation, proteins, and cyclooxygenase-2 mRNA [186]. Z. officinale terpenoids significantly rendered endometrial cancer cells ineffective by promoting the stimulation of p53 [178]. In addition, the combination of 10-gingerol, 8-gingerol, 6-gingerol, and 6-shogaol prevented the rapid multiplication of PC-3 prostate cancer cells, thereby providing cytoprotective effects [186,187]. Other studies on ginger’s cytoprotective effects reported ginger powder suppressing the synthesis of the COX-1 enzyme associated with intestinal cancers [188]. Similarly, a decrease in the synthesis of metalloproteinase-9 and the colonization of breast cancer cells was demonstrated by 6-shogaol [189]. In addition, 6-gingerol stimulates the generation and formation of new blood vessels, aiding in the prevention of the spread of cancer cells [190]. Preventing the synthesis of prostaglandin synthase or 5-lipoxygenase with gingerol and shogaol effectively inhibits the expression of prostaglandins and leukotrienes [191,192]. Although the rhizome is commonly used, all the parts of ginger are utilized in African traditional medicine [92].

3.2.8. Momordica charantia (Fam. Cucurbitaceae) [Bitter Melon]

Bitter melon (Momordica charantia) has been used as a medicinal plant to treat viral and gastrointestinal infections and for ritual purposes in Africa [193]. Bitter melon has been traditionally used to treat diabetes [194]. It contains several bioactive compounds that contribute to its antiviral and antioxidant activities [193,195,196]. The fruit contains minerals, vitamins, phenolic compounds, triterpenes, lipids, proteins, glycosides, steroids, saponins, and flavonoids [195].
M. charantia possessed antiviral activities and was reported to be effective against HIV-1, dengue virus, and hepatitis B [197]. Rebultan (1995) reported that M. charantia significantly increased and normalized CD4 count and CD4/CD8 ratio in HIV-infected persons while reducing recurrent respiratory infections [198].
In addition, M. charantia has been suggested as a promising anticancer agent whose bioactive compounds target cancer cells and are used to correct metabolic aberrations [199]. Autophagy and apoptosis are the mechanisms of action of M. charantia-mediated cell death in colon and breast cancers, respectively [200,201]. The plant’s potential medicinal effects and applications for HIV, diabetes, and cancers made it a good candidate for the treatment of pandemic-related viral diseases and to boost immunity in poor African populations where sophisticated healthcare systems are not available [194,197,200,202]. The variety of steroids and protein compounds isolated from M. charantia, such as kuguacin C and kuguacin E, give the plant its antiviral properties. In a recent review, Jia et al. (2017) summarized the antiviral activity of the Momordica anti-HIV protein of 30 kD (MAP30). The extracted protein from M. charantia inhibits HIV-1 DNA replication in monocytes and selectively kills lymphocytes and macrophage-infected with HIV with minimal toxicity to the cells unaffected by HIV [196]. With a rich collection of phytochemicals and years of successful application in managing and preventing various diseases, M. charantia is a potential source of relief in managing Africa’s present and future epidemics and pandemics.

3.2.9. Curcuma longa L. (Fam. Zingiberaceae) [Tumeric]

Several African scientists have reported the use of C. longa in African traditional folk medicine and its use as a food spice [203,204,205,206]. Although the plant is cultivated throughout the entire continent of Africa and other parts of the world, Western and Eastern Africa seem to have wider plant cultivation than the rest of Africa [207]. C. longa has been traditionally reported for use in conjunctivitis, smallpox, and sinusitis [205,206,208]. The plant has antioxidant, anticancer, immunomodulator, and antimicrobial properties [206,208]. These pharmacological potentials and properties of C. longa have been exploited in Africa for pandemics and epidemics [208]. Curcuminoids, quercetin, curcumin, zingiberine, borneol, alpha-phellandrene, and a variety of sesquiterpenes are some of the bioactive phytochemicals found in C. longa [204,206,208]. Aggarwal et al. (2016) reported curcumin as a potent antioxidant by suppressing NF-κB and NF-α, in addition to its antibacterial effect on organisms, such as Vibrio cholera and Klebsiella pneumonia [208]. Furthermore, African C. longa possessed substantial antiviral activities making it a potential plant in pandemics associated with viruses. The plant is effective against HIV-1, H1N1, hepatitis C, parainfluenza virus type 3, H6N1, human papillomavirus, and coxsackievirus B3 [204,206,208]. The ability of curcumin to inhibit viral hemagglutination, suppress viral replication, and down-regulate viral transcription made curcumin a candidate for use in pandemics [208]. The antibacterial, antiviral, anti-inflammatory, and antioxidant activities of C. longa made the plant a valuable and potential therapy in pandemics throughout Africa [209].
The bioactive compounds in medicinal plants, their pharmacologic activity, and their potential to mitigate infectious diseases during epidemics and pandemics are presented in Table 2 and Figure 2.

4. Discussion

Fermentation processes are effective food preservation methods and valuable transformation processes that strongly affect human nutrition and diet globally. Other than improving food digestibility and palatability (development of food texture, flavor, and aroma), fermentation can reduce or eliminate toxic compounds and produce bioactive substances that can exert a protective action against undesirable micro-organisms, including pathogens [211]. In addition, compared to raw food materials, fermented foods possess an increased dietary value (e.g., linked to the production of micronutrients) with potential positive impacts on consumers’ health. Lactic acid bacteria are a group of gram-positive bacteria mainly involved in food and feed fermentation and generally associated with healthy gut mucosa in animals and humans. LAB is prominent in all traditional fermentations except for alcoholic fermentation (created by yeasts). If administered by diet, both LAB and some yeast species have exhibited potential probiotic effects associated with beneficial health effects for humans and animals. These effects mainly rely on probiotics’ ability to host gut colonization and the maintenance of suitable intestinal microflora homeostasis, which is central for many health-related aspects, including metabolic, and neurobehavioral immunomodulation [212,213]. Although the multiple mechanisms involved have not been fully elucidated, probiotics can boost both innate and acquired immune systems [214]. Thus, probiotics can potentially be active in preventing or treating infectious diseases in the gastrointestinal and upper respiratory tracts [215]. Foods and fermented products containing probiotics showed significant potential effects on preventing and treating viral diseases, including COVID-19 [216,217]. Recently, the potential role of vitamin K deficiency as a risk factor for the severity of COVID-19 has been investigated. In particular, due to its longer half-life, and greater extrahepatic potential (compared to the K1 form), vitamin K2, of which dairy foods are a significant dietary source [65], could play a prominent role. Vitamin K2 has a key role in bone formation, blood coagulation, inhibition of calcification in arteries, and thus, in cardiovascular health. Some premorbid conditions, such as hypertension, diabetes, cardiovascular diseases, and obesity, seem to increase the morbidity and mortality of COVID-19. Janssen et al. (2021) made the observation that such disorders are associated with elastic fiber pathologies as well as vitamin K insufficiency. They, therefore, hypothesized that vitamin K could represent the missing link between pulmonary damage and thrombogenicity [218]. Linneberg et al. (2021) have recently tested this hypothesis. Results showed that vitamin K status was markedly lower in hospitalized COVID-19 patients compared to population controls and that low vitamin K status was associated with mortality in patients with COVID-19 in age- and sex-adjusted analyses. These findings suggest that vitamin K could play a role in the disease mechanisms in COVID-19. However, comorbidities could be part of the causal pathway or confounders of the association of vitamin K status with mortality. Whether vitamin K supplementation in COVID-19 patients can change the course of the disease and prevent death or long-term consequences of COVID-19 remains to be tested in randomized clinical trials [219].
To properly evaluate the health risks and benefits associated with consuming traditional fermented foods, it is pivotal to acquire deeper knowledge about the complex microbial ecology and dynamics behind traditional fermentation processes. For instance, further research are required to better characterize key aspects, such as the production of long-chain vitamin K2 in LAB, the interactions of the vitamin K2-producing bacteria, and the total amounts of the different MKs in fermented foods [220]. These studies should also include a complete characterization of natural pro-technological microbial communities colonizing raw food materials and spoilage, and harmful micro-organisms contaminating fermented foods. Nowadays, omics approaches, such as phylobiomics, metagenomics, and metatranscriptomics, are entirely changing the study of microbial food ecology, providing new insights into microbial consortia and their dynamics in fermented foods [221].
Traditional fermented foods constitute a significant component of African diets, including several edible products starting from a wide range of raw food materials, such as cereals and other grains, milk, meat, and fish. Traditional fermentation methods rely on spontaneous fermentation and inoculated fermentations. Spontaneous fermentations involve the action of both endogenous enzymes and micro-organisms naturally present in food raw materials under water activity, temperature, and time conditions. Spontaneous fermentation processes cannot be fully controlled or predicted because they depend on complex and heterogeneous microbial communities. This condition can lead to slowed or even failed fermentation processes and variations in fermented food quality. Inoculated fermentation methods are based on the addition of a small portion of fermented food to the raw food material to be fermented. This process can stabilize the composition of fermenting microbial communities and accelerate fermentation rates. African fermented foods and beverages are produced using different types of fermentation: lactic acid and alcoholic fermentation are the most diffuse, followed by acetic acid and alkaline fermentation [47].
On the other hand, humans have used herbal remedies since ancient times. Due to Africa’s rich flora and fauna, the continent has extensively used medicinal plants for various ailments, even before scientific discoveries [204]. Medicinal plants still play a vital role in treating any disease in Africa, and in many communities, they are the primary healthcare or integrated into the healthcare system [222,223]. The World Health Organization reported that as of 2020, more than 34 research institutes on the African continent are dedicated to indigenous medicinal research, with approximately forty countries having traditional medicine policies [224]. The COVID-19 pandemic further highlighted the traditional and herbal remedies used in Africa to tackle epidemics and their use in alleviating or managing symptoms associated with pandemics [225,226].
In addition to the variety of foods and medicinal plants found on the African continent that play an essential role in providing community resilience against infectious diseases during epidemics and pandemics, foods from other continents have also been reported to provide immunity against epidemics and pandemics. For instance, Chinese herbal medicines have also been reported to help prevent and manage viral diseases [227]. For instance, Astragulus membranaceus treats common upper respiratory infections and the common cold [228]. Ginseng root is valuable in preventing viral respiratory infections, such as those due to strains of influenza [229,230]. At the same time, Pelargonium sidoides is an efficacious herbal therapy for inhibiting respiratory viruses’ replication [230].
Additionally, documented evidence about preventing SARS and H1N1 influenza in high-risk people implies that Chinese herbal remedies could provide an alternative strategy as immune boosters in the present and future epidemics and pandemics [228]. Other traditional Chinese bioactive food compounds, such as kaempferol, quercetic, flavonoids from litchi seeds, and phenolic compounds, have been shown to inhibit SARS 3-chymotrypsin-like protease (3CLpro) enzymatic activity. Additionally, the 3CLpro enzyme is essential for SARS-CoV replication and has been suggested as a potential agent for SARS-CoV prevention and supportive care for COVID-19 patients [231,232].
Other than Chinese herbal remedies, the Mediterranean diet (MD) provides optimal nutritional quality associated with diverse anti-inflammatory and metabolic properties and immunocompetence [233]. The traditional Mediterranean diet is plant-based and rich in fresh vegetables, fruits, nuts, whole grains, olive oil, and fish. Greene et al. [234] showed an inverse association between compliance with the Mediterranean diet and COVID-19 pandemic cases and deaths in some European countries.
The MD is rich in fibers, folates, selenium, β-carotene, flavonoids, omega-3 fatty acids, mono-unsaturated fatty acids, and vitamins C, and E. The inverse association between MD and COVID-19 is attributed to the optimal nutritional quality and the anti-inflammatory profile of Mediterranean diets, thereby conferring immune support for COVID-19 [234].
Furthermore, the overall well-being associated with MD adherence is attributed to a decrease in the risk of common COVID-19 comorbidities, such as cancer, cerebrovascular disease, chronic kidney disease, chronic obstructive pulmonary disease, diabetes type 2, cardiovascular disease, hypertension, and obesity [225,226,227,228,229,230,231,232,233,234,235,236,237]. The rich fiber in a Mediterranean diet modulates nutrient satiety and absorption, which contributes to healthy weight maintenance. Undoubtedly, the significant role of plant-based diets and nutrition in supporting the immune response and providing optimal nutritional quality for immunocompetence, whether in Africa, Asia, or the Mediterranean, is due primarily to the bioactive compounds found in the plants. Hence the need to explore bioactive plant-based therapies for future epidemics and pandemics.
Medicinal plants have a wide range of chemical diversity. They have contributed significantly to drug discovery due to their minimal adverse effects, safety, efficacy, availability, accessibility, and general acceptability within most communities, especially in Africa. The ability of medicinal plants to exhibit antioxidant, antiviral, antidiabetic, anti-inflammatory, anticancer, and immunomodulatory properties has been well documented [238,239]. The bioactive compounds found in medicinal plants give them a broad spectrum of pharmacological and therapeutic activities. Phenolics, organosulfur compounds, flavonoids, coumarins, terpenoids, alkaloids, and steroids are some of the bioactive substances found in medicinal plants that accord their pharmacotherapeutic benefits [240]. For instance, bioactive peptides found in plants have been reported to have little or no toxicity, do not accumulate in the body, and are very effective even at low concentrations. In a recent review, Akbarian et al. [241] summarized the applications of bioactive peptides as antihypertensive, antioxidants, antithrombotic, antimicrobial, antiaging, metal chelating, and in lowering cholesterol [241]. Similarly, antioxidants in foods and medicinal plants possess anticancer, anti-inflammatory, antiaging, and immunomodulatory properties [238].

5. Conclusions

Even though personal and public hygiene and vaccinations are the most recommended methods to curb the spread of infections, natural micronutrients in food and herbal medicines can help boost immunity and provide community resilience against infectious organisms in epidemics and pandemics. The diversity of foods and medicinal plants on the African continent could have contributed to the lower rates of COVID-19 deaths reported in the region and other equally essential factors reported by other authors. Bioactive compounds in food and plants significantly support the immune system and help to increase resistance against infectious diseases. The unique foods and medicinal plants found on the African continent could play an essential role in providing community resilience against infectious diseases during epidemics and pandemics. There is a need to investigate nutritional, herbal, and traditional practices in epidemics and pandemics that support healthy living and longevity within the African continent.

Author Contributions

Conceptualization, C.F., G.G., O.E.O.; investigation, G.G., D.C.H.; writing—original draft preparation, C.F., G.G., D.C.H., D.N.A., F.C.O.; writing—review and editing, C.F., G.G., D.C.H., O.E.O.; supervision, C.F., O.E.O. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. World Health Organization (WHO). Coronavirus COVID-19 Dashboard. Available online: https://covid19.who.int (accessed on 8 December 2021).
  2. WHO. Diseases Cost the African Region $2.4 Trillion A Year, Says Who. 2019. Available online: https://www.afro.who.int/news/diseases-cost-african-region-24-trillion-year-says-who (accessed on 8 December 2021).
  3. Anaemene, B. Health and Diseases in Africa. In The Development of Africa; Springer: Berlin/Heidelberg, Germany, 2018; pp. 207–226. [Google Scholar]
  4. WHO. The Environmental Burden of Disease in Africa. 2015. Available online: https://apps.who.int/iris/bitstream/handle/10665/177155/Synt_R_3.pdf?sequence=3&isAllowed=y (accessed on 17 May 2022).
  5. Oleribe, O.O.; Suliman, A.A.; Taylor-Robinson, S.D.; Corrah, T. Possible Reasons Why Sub-Saharan Africa Experienced a Less Severe COVID-19 Pandemic in 2020. J. Multidiscip. Healthc. 2021, 14, 3267–3271. [Google Scholar] [CrossRef] [PubMed]
  6. Cámara, M.; Sánchez-Mata, M.; Fernández-Ruiz, V.; Cámara, R.; Cebadera, E.; Domínguez, L. A Review of the Role of Micronutrients and Bioactive Compounds on Immune System Supporting to Fight against the COVID-19 Disease. Foods 2021, 10, 1088. [Google Scholar] [CrossRef] [PubMed]
  7. WHO. World Health Organization Working Together: An Integration Resource Guide for Immunization Services throughout the Life Course. 2018. Available online: https://apps.who.int/iris/bitstream/handle/10665/276546/9789241514736-eng.pdf? (accessed on 17 May 2022).
  8. Achi, O.K.; Asamudo, N.U. Cereal-Based Fermented Foods of Africa as Functional Foods. In Bioactive Molecules in Food; Mérillon, J.-M., Ramawat, K.G., Eds.; Reference Series in Phytochemistry; Springer International Publishing: Cham, Switzerland, 2019; pp. 1527–1558. [Google Scholar] [CrossRef]
  9. Flibert, G.; Abel, T.; Aly, S. African cassava Traditional Fermented Food: The Microorganism’s Contribution to their Nutritional and Safety Values-A Review. Int. J. Curr. Microbiol. Appl. Sci. 2016, 5, 664–687. [Google Scholar] [CrossRef] [Green Version]
  10. Phiri, S.; Schoustra, S.E.; Van Den Heuvel, J.; Smid, E.J.; Shindano, J.; Linnemann, A. Fermented Cereal-Based Munkoyo Beverage: Processing Practices, Microbial Diversity and Aroma Compounds. PLoS ONE 2019, 14, e0223501. [Google Scholar] [CrossRef] [Green Version]
  11. Melini, F.; Melini, V.; Luziatelli, F.; Ficca, A.G.; Ruzzi, M. Health-Promoting Components in Fermented Foods: An Up-to-Date Systematic Review. Nutrients 2019, 11, 1189. [Google Scholar] [CrossRef] [Green Version]
  12. Laurent-Babot, C.; Guyot, J.-P. Should Research on the Nutritional Potential and Health Benefits of Fermented Cereals Focus More on the General Health Status of Populations in Developing Countries? Microorganisms 2017, 5, 40. [Google Scholar] [CrossRef] [Green Version]
  13. Mikkelsen, K.; Apostolopoulos, V. Vitamin B12, Folic Acid, and the Immune System. In Nutrition and Immunity; Springer: Berlin/Heidelberg, Germany, 2019; pp. 103–114. [Google Scholar]
  14. Saubade, F.; Hemery, Y.M.; Rochette, I.; Guyot, J.-P.; Humblot, C. Influence of fermentation and other processing steps on the folate content of a traditional African cereal-based fermented food. Int. J. Food Microbiol. 2018, 266, 79–86. [Google Scholar] [CrossRef]
  15. Bationo, F.; Humblot, C.; Songré-Ouattara, L.T.; Hama-Ba, F.; Le Merrer, M.; Chapron, M.; Kariluoto, S.; Hemery, Y.M. Total folate in West African cereal-based fermented foods: Bioaccessibility and influence of processing. J. Food Compos. Anal. 2019, 85, 103309. [Google Scholar] [CrossRef]
  16. Saubade, F.; Hemery, Y.M.; Guyot, J.-P.; Humblot, C. Lactic acid fermentation as a tool for increasing the folate content of foods. Crit. Rev. Food Sci. Nutr. 2016, 57, 3894–3910. [Google Scholar] [CrossRef]
  17. Omemu, A.; Oyewole, O.; Bankole, M. Significance of yeasts in the fermentation of maize for ogi production. Food Microbiol. 2007, 24, 571–576. [Google Scholar] [CrossRef]
  18. Adebo, O.A. African Sorghum-Based Fermented Foods: Past, Current and Future Prospects. Nutrients 2020, 12, 1111. [Google Scholar] [CrossRef] [PubMed]
  19. Pedersen, L.; Owusu-Kwarteng, J.; Thorsen, L.; Jespersen, L. Biodiversity and probiotic potential of yeasts isolated from Fura, a West African spontaneously fermented cereal. Int. J. Food Microbiol. 2012, 159, 144–151. [Google Scholar] [CrossRef] [PubMed]
  20. Owusu-Kwarteng, J.; Tano-Debrah, K.; Akabanda, F.; Jespersen, L. Technological properties and probiotic potential of Lactobacillus fermentum strains isolated from West African fermented millet dough. BMC Microbiol. 2015, 15, 261. [Google Scholar] [CrossRef] [PubMed]
  21. Greppi, A.; Saubade, F.; Botta, C.; Humblot, C.; Guyot, J.-P.; Cocolin, L. Potential probiotic Pichia kudriavzevii strains and their ability to enhance folate content of traditional cereal-based African fermented food. Food Microbiol. 2017, 62, 169–177. [Google Scholar] [CrossRef]
  22. Motey, G.A.; Johansen, P.G.; Owusu-Kwarteng, J.; Ofori, L.A.; Obiri-Danso, K.; Siegumfeldt, H.; Larsen, N.; Jespersen, L. Probiotic potential of Saccharomyces cerevisiae and Kluyveromyces marxianus isolated from West African spontaneously fermented cereal and milk products. Yeast 2020, 37, 403–412. [Google Scholar] [CrossRef] [PubMed]
  23. Imade, E.E.; Omonigho, S.E.; Babalola, O.O.; Enagbonma, B.J. Lactic acid bacterial bacteriocins and their bioactive properties against food-associated antibiotic-resistant bacteria. Ann. Microbiol. 2021, 71, 1–14. [Google Scholar] [CrossRef]
  24. Kumar, V.; Sheoran, P.; Gupta, A.; Yadav, J.; Tiwari, S.K. Antibacterial property of bacteriocin produced by Lactobacillus plantarum LD4 isolated from a fermented food. Ann. Microbiol. 2016, 66, 1431–1440. [Google Scholar] [CrossRef]
  25. Liburdi, K.; Bernini, R.; Esti, M. Fermented Beverages: Geographical Distribution and Bioactive Compounds with Health Benefits. In New and Future Developments in Microbial Biotechnology and Bioengineering; Elsevier: Amsterdam, The Netherlands, 2020; pp. 131–151. [Google Scholar]
  26. Hotessa, N.; Robe, J. Ethiopian Indigenous Traditional Fermented Beverage: The Role of the Microorganisms toward Nutritional and Safety Value of Fermented Beverage. Int. J. Microbiol. 2020, 2020, 8891259. [Google Scholar] [CrossRef]
  27. Lemi, B.W. Microbiology of Ethiopian Traditionally Fermented Beverages and Condiments. Int. J. Microbiol. 2020, 2020, 1478536. [Google Scholar] [CrossRef]
  28. Hjortmo, S.B.; Hellström, A.M.; Andlid, T.A. Production of Folates by Yeasts in Tanzanian Fermented Togwa. FEMS Yeast Res. 2008, 8, 781–787. [Google Scholar] [CrossRef] [Green Version]
  29. Adebiyi, J.A.; Kayitesi, E.; Adebo, O.A.; Changwa, R.; Njobeh, P.B. Food fermentation and mycotoxin detoxification: An African perspective. Food Control 2019, 106, 106731. [Google Scholar] [CrossRef]
  30. Corbo, M.R.; Campaniello, D.; Speranza, B.; Altieri, C.; Sinigaglia, M.; Bevilacqua, A. Neutralisation of toxins by probiotics during the transit into the gut: Challenges and perspectives. Int. J. Food Sci. Technol. 2018, 53, 1339–1351. [Google Scholar] [CrossRef]
  31. Ezekiel, C.N.; Ayeni, K.; Misihairabgwi, J.M.; Somorin, Y.; Chibuzor-Onyema, I.E.; Oyedele, O.A.; Abia, W.A.; Sulyok, M.; Shephard, G.S.; Krska, R. Traditionally Processed Beverages in Africa: A Review of the Mycotoxin Occurrence Patterns and Exposure Assessment. Compr. Rev. Food Sci. Food Saf. 2018, 17, 334–351. [Google Scholar] [CrossRef] [PubMed]
  32. Nafuka, S.N.; Misihairabgwi, J.M.; Bock, R.; Ishola, A.; Sulyok, M.; Krska, R. Variation of Fungal Metabolites in Sorghum Malts Used to Prepare Namibian Traditional Fermented Beverages Omalodu and Otombo. Toxins 2019, 11, 165. [Google Scholar] [CrossRef] [Green Version]
  33. Chiocchetti, G.M.; Jadán-Piedra, C.; Monedero, V.; Zúñiga, M.; Vélez, D.; Devesa, V. Use of lactic acid bacteria and yeasts to reduce exposure to chemical food contaminants and toxicity. Crit. Rev. Food Sci. Nutr. 2018, 59, 1534–1545. [Google Scholar] [CrossRef] [Green Version]
  34. Sharma, R.; Garg, P.; Kumar, P.; Bhatia, S.K.; Kulshrestha, S. Microbial Fermentation and Its Role in Quality Improvement of Fermented Foods. Fermentation 2020, 6, 106. [Google Scholar] [CrossRef]
  35. Mrvčić, J.; Stanzer, D.; Šolić, E.; Stehlik-Tomas, V. Interaction of lactic acid bacteria with metal ions: Opportunities for improving food safety and quality. World J. Microbiol. Biotechnol. 2012, 28, 2771–2782. [Google Scholar] [CrossRef]
  36. Orisakwe, O.E.; Amadi, C.N.; Frazzoli, C.; Dokubo, A. Nigerian foods of probiotics relevance and chronic metal exposure: A systematic review. Environ. Sci. Pollut. Res. 2020, 27, 19285–19297. [Google Scholar] [CrossRef]
  37. Gagaoua, M.; Boudechicha, H.-R. Ethnic meat products of the North African and Mediterranean countries: An overview. J. Ethn. Foods 2018, 5, 83–98. [Google Scholar] [CrossRef]
  38. Dullius, A.; Rama, G.R.; Giroldi, M.; Goettert, M.I.; Lehn, D.N.; de Souza, C.F.V. Bioactive Peptide Production in Fermented Foods. In Current Developments in Biotechnology and Bioengineering; Elsevier: Amsterdam, The Netherlands, 2022; pp. 47–72. [Google Scholar]
  39. Ben Belgacem, Z.; Abriouel, H.; Ben Omar, N.; Lucas, R.; Martínez-Canamero, M.; Gálvez, A.; Manai, M. Antimicrobial activity, safety aspects, and some technological properties of bacteriocinogenic Enterococcus faecium from artisanal Tunisian fermented meat. Food Control 2010, 21, 462–470. [Google Scholar] [CrossRef]
  40. Hanchi, H.; Mottawea, W.; Sebei, K.; Hammami, R. The Genus Enterococcus: Between Probiotic Potential and Safety Concerns—An Update. Front. Microbiol. 2018, 9, 1791. [Google Scholar] [CrossRef] [PubMed]
  41. Boudechicha, H.-R.; Nasri, I.; Bennaceur, Z.; Sellama, M.; Hafid, K.; Boudjellal, A.; Gagaoua, M. Microbiological changes during the preparation steps of Khliaa Ezir: A traditional cured meat product of Algeria. Integr. Food Nutr. Metab. 2017, 4, 1–5. [Google Scholar] [CrossRef] [Green Version]
  42. Benlacheheb, R.; Becila, S.; Sentandreu, A.M.; Hafid, K.; Boudechicha, H.-R.; Boudjellal, A. El Gueddid, a traditional Algerian dried salted meat: Physicochemical, microbiological characteristics and proteolysis intensity during its manufacturing process and ripening. Food Sci. Technol. Int. 2019, 25, 347–355. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Mostefa, N.; Abid, A.; Boumédiène, K.M. Preliminary probiotic potential of selected aerococcus spp., enterococcus spp., and weisella sp. From algerian guedid. J. Microbiol. Biotechnol. Food Sci. 2021, 10, e2937. [Google Scholar] [CrossRef]
  44. Bader, R.; Becila, S.; Ruiz, P.; Djeghim, F.; Sanah, I.; Boudjellal, A.; Gatellier, P.; Portanguen, S.; Talon, R.; Leroy, S. Physicochemical and microbiological characteristics of El-Guedid from meat of different animal species. Meat Sci. 2021, 171, 108277. [Google Scholar] [CrossRef] [PubMed]
  45. Laranjo, M.; Potes, M.E.; Elias, M. Role of Starter Cultures on the Safety of Fermented Meat Products. Front. Microbiol. 2019, 10, 853. [Google Scholar] [CrossRef] [Green Version]
  46. Pilevar, Z.; Hosseini, H.; Beikzadeh, S.; Khanniri, E.; Alizadeh, A.M. Application of Bacteriocins in Meat and Meat Products: An Update. Curr. Nutr. Food Sci. 2020, 16, 120–133. [Google Scholar] [CrossRef]
  47. Mokoena, M.P.; Mutanda, T.; Olaniran, A.O. Perspectives on the probiotic potential of lactic acid bacteria from African traditional fermented foods and beverages. Food Nutr. Res. 2016, 60, 29630. [Google Scholar] [CrossRef] [Green Version]
  48. Anihouvi, V.B.; Kindossi, J.M.; Hounhouigan, J.D. Processing and Quality Characteristics of Some Major Fermented Fish Products from Africa: A Critical Review. Int. Res. J. Biol. Sci. 2012, 1, 72–84. [Google Scholar]
  49. Kindossi, J.M.; Anihouvi, V.B.; Vieira-Dalodé, G.; Akissoé, N.H.; Hounhouigan, D.J. Optimization of the marinating conditions of cassava fish ( Pseudotolithus sp.) fillet for Lanhouin production through application of Doehlert experimental design. Food Sci. Nutr. 2015, 4, 261–268. [Google Scholar] [CrossRef]
  50. Anihouvi, D.G.H.; Kpoclou, Y.E.; Massih, M.A.; Afé, O.H.I.; Assogba, M.F.; Covo, M.; Scippo, M.; Hounhouigan, D.J.; Anihouvi, V.; Mahillon, J. Microbiological characteristics of smoked and smoked-dried fish processed in Benin. Food Sci. Nutr. 2019, 7, 1821–1827. [Google Scholar] [CrossRef] [PubMed]
  51. Fall, M.; Diop, M.B.; Montet, D.; Maiga, A.S.; Guiro, A.T. Fermentation Du Poisson En Afrique de l’Ouest et Défis Sociétaux Pour Une Amélioration Qualitative Des Produits (Adjuevan, Guedj et Lanhouin): Revue de La Littérature. Cah. Agric. 2019, 28, 7. [Google Scholar] [CrossRef] [Green Version]
  52. Xu, Y.; Zang, J.; Regenstein, J.M.; Xia, W. Technological roles of microorganisms in fish fermentation: A review. Crit. Rev. Food Sci. Nutr. 2020, 61, 1000–1012. [Google Scholar] [CrossRef] [PubMed]
  53. Sanni, A.I.; Asiedu, M.; Ayernor, G.S. Microflora and Chemical Composition of Momoni, a Ghanaian Fermented Fish Condiment. J. Food Compos. Anal. 2002, 15, 577–583. [Google Scholar] [CrossRef]
  54. Farag, M.A.; Zain, A.E.; Hariri, M.L.; El Aaasar, R.; Khalifa, I.; Elmetwally, F. Potential food safety hazards in fermented and salted fish in Egypt (Feseekh, Renga, Moloha) as case studies and controlling their manufacture using HACCP system. J. Food Saf. 2022, 42, e12973. [Google Scholar] [CrossRef]
  55. Anihouvi, V.; Sakyi-Dawson, E.; Ayernor, G.; Hounhouigan, J. Microbiological changes in naturally fermented cassava fish (Pseudotolithus sp.) for lanhouin production. Int. J. Food Microbiol. 2007, 116, 287–291. [Google Scholar] [CrossRef] [PubMed]
  56. Koffi-Nevr, R.; Ouina, T.; Koussemon, M.; Brou, K. Chemical Composition and Lactic Microflora of Adjuevan, A Traditional Ivorian Fermented Fish Condiment. Pak. J. Nutr. 2011, 10, 332–337. [Google Scholar] [CrossRef] [Green Version]
  57. Kouakou, A.C.; N’Guessan, K.F.; Durand, N.; Thomas, D.A.; Montet, D.; Djè, M.K. Molecular bacterial characterization and free amino acids composition in Ivorian traditional fermented fish produced by two methods. Fish. Sci. 2012, 78, 1125–1136. [Google Scholar] [CrossRef]
  58. Clémentine, K.-K.A.; Florent, N.G.K.; Solange, A.; Didier, M.; Marcellin, D.K. Salt concentration effect on yeast diversity of the Ivorian traditional fermented fish adjuevan. GSC Biol. Pharm. Sci. 2020, 13, 087–094. [Google Scholar] [CrossRef]
  59. Lara-Hidalgo, C.E.; Hernández-Sánchez, H.; Hernández-Rodríguez, C.; Dorantes-Álvarez, L. Yeasts in Fermented Foods and Their Probiotic Potential. Austin J. Nutr. Metab. 2017, 4, 1045. [Google Scholar]
  60. Cheng, R.; Mantovani, A.; Frazzoli, C. Analysis of Food Safety and Security Challenges in Emerging African Food Producing Areas through a One Health Lens: The Dairy Chains in Mali. J. Food Prot. 2016, 80, 57–67. [Google Scholar] [CrossRef] [PubMed]
  61. Frazzoli, C. Field anthropological research for context-effective risk analysis science in traditional cultures: The case of Senegal. J. Glob. Health Rep. 2020, 4, e2020043. [Google Scholar] [CrossRef]
  62. Fardet, A.; Rock, E. In vitro and in vivo antioxidant potential of milks, yoghurts, fermented milks and cheeses: A narrative review of evidence. Nutr. Res. Rev. 2017, 31, 52–70. [Google Scholar] [CrossRef] [Green Version]
  63. Gille, D.; Schmid, A. Vitamin B12 in meat and dairy products. Nutr. Rev. 2015, 73, 106–115. [Google Scholar] [CrossRef]
  64. Liu, Y.; Van Bennekom, E.O.; Zhang, Y.; Abee, T.; Smid, E.J. Long-chain vitamin K2 production in Lactococcus lactis is influenced by temperature, carbon source, aeration and mode of energy metabolism. Microb. Cell Factories 2019, 18, 1–14. [Google Scholar] [CrossRef] [Green Version]
  65. Walther, B.; Karl, J.P.; Booth, S.L.; Boyaval, P. Menaquinones, Bacteria, and the Food Supply: The Relevance of Dairy and Fermented Food Products to Vitamin K Requirements. Adv. Nutr. Int. Rev. J. 2013, 4, 463–473. [Google Scholar] [CrossRef] [Green Version]
  66. Mattiello, S.; Caroprese, M.; Matteo, C.G.; Fortina, R.; Martini, A.; Martini, M.; Parisi, G.; Russo, C.; Zecchini, M. ASPA Commission “Animal Productions in Development Cooperation Projects” Typical dairy products in Africa from local animal resources. Ital. J. Anim. Sci. 2017, 17, 740–754. [Google Scholar] [CrossRef] [Green Version]
  67. Jans, C.; Meile, L.; Kaindi, D.W.M.; Kogi-Makau, W.; Lamuka, P.; Renault, P.; Kreikemeyer, B.; Lacroix, C.; Hattendorf, J.; Zinsstag, J.; et al. African fermented dairy products—Overview of predominant technologically important microorganisms focusing on African Streptococcus infantarius variants and potential future applications for enhanced food safety and security. Int. J. Food Microbiol. 2017, 250, 27–36. [Google Scholar] [CrossRef]
  68. Agyei, D.; Owusu-Kwarteng, J.; Akabanda, F.; Akomea-Frempong, S. Indigenous African fermented dairy products: Processing technology, microbiology and health benefits. Crit. Rev. Food Sci. Nutr. 2019, 60, 991–1006. [Google Scholar] [CrossRef]
  69. Uzeh, R.E.; Ohenhen, R.E.; Rojugbokan, A.K. Microbiological and Nutritional Qualities of Dairy Products: Nono and Wara. Nat. Sci. 2006, 4, 37–40. [Google Scholar]
  70. Awad, S. Microbial safety criteria and quality of traditional Egyptian Karish cheese. Afr. J. Microbiol. Res. 2016, 10, 804–812. [Google Scholar] [CrossRef] [Green Version]
  71. Nduko, J.M.; Matofari, J.W.; Nandi, Z.O.; Sichangi, M.B. Spontaneously Fermented Kenyan Milk Products: A Review of the Current State and Future Perspectives. Afr. J. Food Sci. 2017, 11, 1–11. [Google Scholar] [CrossRef]
  72. Maleke, M.S.; Adefisoye, M.A.; Doorsamy, W.; Adebo, O.A. Processing, nutritional composition and microbiology of amasi: A Southern African fermented milk product. Sci. Afr. 2021, 12, e00795. [Google Scholar] [CrossRef]
  73. Akinyemi, M.O.; Ayeni, K.I.; Ogunremi, O.R.; Adeleke, R.A.; Oguntoyinbo, F.A.; Warth, B.; Ezekiel, C.N. A review of microbes and chemical contaminants in dairy products in sub-Saharan Africa. Compr. Rev. Food Sci. Food Saf. 2021, 20, 1188–1220. [Google Scholar] [CrossRef] [PubMed]
  74. Todorov, S.D. Bacteriocin production by Lactobacillus plantarum AMA-K isolated from Amasi, a Zimbabwean fermented milk product and study of the adsorption of bacteriocin AMA-K to Listeria sp. Braz. J. Microbiol. 2008, 39, 178–187. [Google Scholar] [CrossRef] [Green Version]
  75. Mosbah, S.; Boudjenah-Haroun, S.; Eddoud, A.; Boual, Z. Therapeutic Aptitude of Fermented Camel Milk: Case of Antimicrobial Activity of Whey Proteins. Int. J. Agric. Biol. Eng. 2018, 1, 19–30. [Google Scholar]
  76. Muthukumaran, M.S.; Mudgil, P.; Baba, W.N.; Ayoub, M.A.; Maqsood, S. A comprehensive review on health benefits, nutritional composition and processed products of camel milk. Food Rev. Int. 2022, 1–37. [Google Scholar] [CrossRef]
  77. Behrouz, S.; Saadat, S.; Memarzia, A.; Sarir, H.; Folkerts, G.; Boskabady, M.H. The Antioxidant, Anti-Inflammatory and Immunomodulatory Effects of Camel Milk. Front. Immunol. 2022, 13. [Google Scholar] [CrossRef]
  78. Nyamakwere, F.; Esposito, G.; Dzama, K.; Raffrenato, E. A review of artisanal cheese making: An African perspective. S. Afr. J. Anim. Sci. 2021, 51, 296–309. [Google Scholar] [CrossRef]
  79. Abdelfatah, E.N. Identification of Lactic Acid Bacteria in Raw Milk and Kariesh Cheese with Special Reference to Lactococcus garvieae. J. Food Nutr. Sci. 2015, 3, 203. [Google Scholar] [CrossRef]
  80. Olajugbagbe, T.E.; Elugbadebo, O.E.; Omafuvbe, B.O. Probiotic potentials of Pediococuss acidilactici isolated from wara; A Nigerian unripened soft cheese. Heliyon 2020, 6, e04889. [Google Scholar] [CrossRef] [PubMed]
  81. Seini, S.H.; Keita, A.; Sabiou, M.S.M.; Nafiou, A.I.M.; Maazou, B.A.; Sadou, H.; Ibrahim, A.; Issa, O.; Alma, M.M.; Sidikou, R.S.; et al. Microbiological Characteristics and Nutritional Quality of Traditional Tchoukou Cheese from Niger. Int. J. Curr. Microbiol. Appl. Sci. 2018, 7, 317–328. [Google Scholar] [CrossRef]
  82. Doumbouya, I.; Owino, O.; Omolo, K. Probiotic properties of lactic acid bacteria isolated from “tchoukou” traditional milk cheeses produced in selected region of niger. Int. J. Food Sci. 2022, 5, 1–15. [Google Scholar] [CrossRef]
  83. Guetouache, M.; Guessas, B. Characterization and identification of lactic acid bacteria isolated from traditional cheese (Klila) prepared from cows milk. Afr. J. Microbiol. Res. 2015, 9, 71–77. [Google Scholar] [CrossRef] [Green Version]
  84. Marino, V.M.; Belbeldi, A.; La Terra, S.; Manenti, M.; Licitra, G.; Carpino, S. Survey of Fat Soluble Antioxidants, Linolenic Acid and Conjugated Linoleic Acid Content of Traditional Algerian Bouhezza Cheese. J. Food Agric. Environ. 2012, 10, 186–190. [Google Scholar]
  85. Ekene, E.N. Garcinia Kola: A Review of Its Ethnomedicinal, Chemical and Pharmacological Properties. Int. J. Curr. Res. Rev. 2014, 6, 1. [Google Scholar]
  86. Maňourová, A.; Leuner, O.; Tchoundjeu, Z.; Van Damme, P.; Verner, V.; Přibyl, O.; Lojka, B. Medicinal Potential, Utilization and Domestication Status of Bitter Kola (Garcinia kola Heckel) in West and Central Africa. Forests 2019, 10, 124. [Google Scholar] [CrossRef] [Green Version]
  87. Seanego, C.T.; Ndip, R.N. Identification and Antibacterial Evaluation of Bioactive Compounds from Garcinia kola (Heckel) Seeds. Molecules 2012, 17, 6569–6584. [Google Scholar] [CrossRef]
  88. Konziase, B. Protective activity of biflavanones from Garcinia kola against Plasmodium infection. J. Ethnopharmacol. 2015, 172, 214–218. [Google Scholar] [CrossRef]
  89. Kalu, W.; Okafor, P.; Ijeh, I.; Eleazu, C. Effect of kolaviron, a biflavanoid complex from Garcinia kola on some biochemical parameters in experimentally induced benign prostatic hyperplasic rats. Biomed. Pharmacother. 2016, 83, 1436–1443. [Google Scholar] [CrossRef]
  90. BC, I.C.; Maduka Tochukwu, O.D.; Enyoh, C.E.; JM, I.U. Potential Plants for Treatment and Management of COVID-19 in Nigeria. Acad. J. Chem. 2020, 5, 69–80. [Google Scholar]
  91. Oladele, J.O.; Ajayi, E.I.; Oyeleke, O.M.; Oladele, O.T.; Olowookere, B.D.; Adeniyi, B.M.; Oyewole, O.I.; Oladiji, A.T. A systematic review on COVID-19 pandemic with special emphasis on curative potentials of Nigeria based medicinal plants. Heliyon 2020, 6, e04897. [Google Scholar] [CrossRef] [PubMed]
  92. Adeleye, O.A.; Femi-Oyewo, M.N.; Bamiro, O.A.; Bakre, L.G.; Alabi, A.; Ashidi, J.S.; Balogun-Agbaje, O.A.; Hassan, O.M.; Fakoya, G. Ethnomedicinal herbs in African traditional medicine with potential activity for the prevention, treatment, and management of coronavirus disease 2019. Futur. J. Pharm. Sci. 2021, 7, 1–14. [Google Scholar] [CrossRef] [PubMed]
  93. Awogbindin, I.O.; Olaleye, D.O.; Farombi, E.O. Kolaviron Improves Morbidity and Suppresses Mortality by Mitigating Oxido-Inflammation in BALB/c Mice Infected with Influenza Virus. Viral Immunol. 2015, 28, 367–377. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  94. Obi, R.; Olayinka, A.; Adesegun, S. The antiviral activities of Garcinia kola (Heckel.) and Azadirachta indica (A. Juss.) on viruses of public health importance in Nigeria. Int. J. Infect. Dis. 2020, 101, 119. [Google Scholar] [CrossRef]
  95. Nworu, C.S.; Akah, P.A.; Esimone, C.O.; Okoli, C.O.; Okoye, F.B.C. Immunomodulatory Activities of Kolaviron, a Mixture of Three Related Biflavonoids of Garcinia Kola Heckel. Immunopharmacol. Immunotoxicol. 2008, 30, 317–332. [Google Scholar] [CrossRef]
  96. Ukaoma, A.A.; Okechukwu, R.I.; Ukaoma, V.O.; Iwuagwu, M. Phytochemical screening and antibacterial properties of Garcinia kola. J. Phytopharm. 2013, 2, 34–38. [Google Scholar] [CrossRef]
  97. Farombi, E.O. African indigenous plants with chemotherapeutic potentials and biotechnological approach to the production of bioactive prophylactic agents. Afr. J. Biotechnol. 2003, 2, 662–671. [Google Scholar] [CrossRef] [Green Version]
  98. Adaramoye, O.; Awogbindin, I.; Okusaga, J. Effect of Kolaviron, a Biflavonoid Complex from Garcinia kola Seeds, on Ethanol-Induced Oxidative Stress in Liver of Adult Wistar Rats. J. Med. Food 2009, 12, 584–590. [Google Scholar] [CrossRef]
  99. Farombi, E.O.; Shrotriya, S.; Surh, Y.-J. Kolaviron Inhibits Dimethyl Nitrosamine-Induced Liver Injury by Suppressing COX-2 and INOS Expression via NF-ΚB and AP-1. Life Sci. 2009, 84, 149–155. [Google Scholar] [CrossRef]
  100. Farombi, E.O.; Owoeye, O. Antioxidative and Chemopreventive Properties of Vernonia amygdalina and Garcinia biflavonoid. Int. J. Environ. Res. Public Health 2011, 8, 2533–2555. [Google Scholar] [CrossRef] [PubMed]
  101. Salehi, B.; Kumar, N.V.A.; Şener, B.; Sharifi-Rad, M.; Kılıç, M.; Mahady, G.B.; Vlaisavljevic, S.; Iriti, M.; Kobarfard, F.; Setzer, W.N.; et al. Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus. Int. J. Mol. Sci. 2018, 19, 1459. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  102. Okoye, T.C.; Uzor, P.F.; Onyeto, C.A.; Okereke, E.K. Safe African Medicinal Plants for Clinical Studies. In Toxicological Survey of African Medicinal Plants; Elsevier: Amsterdam, The Netherlands, 2014; pp. 535–555. [Google Scholar]
  103. More, G.; Lall, N.; Hussein, A.; Tshikalange, T.E. Antimicrobial Constituents of Artemisia Afra Jacq. Ex Willd. against Periodontal Pathogens. Evid. Based Complement Alternat. Med. 2012, 2012, 252758. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Moyo, P.; Kunyane, P.; Selepe, M.A.; Eloff, J.N.; Niemand, J.; Louw, A.I.; Maharaj, V.J.; Birkholtz, L.-M. Bioassay-guided isolation and identification of gametocytocidal compounds from Artemisia afra (Asteraceae). Malar. J. 2019, 18, 65. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  105. Kshirsagar, S.; Rao, R. Antiviral and Immunomodulation Effects of Artemisia. Medicina 2021, 57, 217. [Google Scholar] [CrossRef] [PubMed]
  106. Du, L.; Chen, J.; Xing, Y.-Q. Eupatilin prevents H2O2-induced oxidative stress and apoptosis in human retinal pigment epithelial cells. Biomed. Pharmacother. 2017, 85, 136–140. [Google Scholar] [CrossRef] [PubMed]
  107. Krishna, S.; Ganapathi, S.; Ster, I.C.; Saeed, M.E.; Cowan, M.; Finlayson, C.; Kovacsevics, H.; Jansen, H.; Kremsner, P.G.; Efferth, T.; et al. A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer. Ebiomedicine 2014, 2, 82–90. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  108. Slezakova, S.; Ruda-Kucerova, J. Anticancer Activity of Artemisinin and its Derivatives. Anticancer. Res. 2017, 37, 5995–6003. [Google Scholar] [CrossRef] [Green Version]
  109. Efferth, T.; Romero, M.R.; Wolf, D.G.; Stamminger, T.; Marin, J.J.G.; Marschall, M. The Antiviral Activities of Artemisinin and Artesunate. Clin. Infect. Dis. 2008, 47, 804–811. [Google Scholar] [CrossRef] [Green Version]
  110. Salehi, B.; Zakaria, Z.A.; Gyawali, R.; Ibrahim, S.A.; Rajkovic, J.; Shinwari, Z.K.; Khan, T.; Sharifi-Rad, J.; Ozleyen, A.; Turkdonmez, E.; et al. Piper Species: A Comprehensive Review on Their Phytochemistry, Biological Activities and Applications. Molecules 2019, 24, 1364. [Google Scholar] [CrossRef] [Green Version]
  111. Efferth, T. Beyond malaria: The inhibition of viruses by artemisinin-type compounds. Biotechnol. Adv. 2018, 36, 1730–1737. [Google Scholar] [CrossRef] [PubMed]
  112. Uzun, T.; Toptas, O. Artesunate: Could Be an Alternative Drug to Chloroquine in COVID-19 Treatment? Chin. Med. 2020, 15, 1–4. [Google Scholar] [CrossRef] [PubMed]
  113. Chen, W. A potential treatment of COVID-19 with TGF-β blockade. Int. J. Biol. Sci. 2020, 16, 1954–1955. [Google Scholar] [CrossRef] [PubMed]
  114. Ene-Obong, H.; Onuoha, N.; Aburime, L.; Mbah, O. Chemical composition and antioxidant activities of some indigenous spices consumed in Nigeria. Food Chem. 2018, 238, 58–64. [Google Scholar] [CrossRef] [PubMed]
  115. Ajibesin, K.; Umoh, U.; Bala, D. The use of medicinal plants to treat sexually transmitted diseases in Nigeria: Ethnomedicinal survey of Niger Delta Region. Int. J. Green Pharm. 2011, 5, 181. [Google Scholar] [CrossRef]
  116. Agbor, G.A.; Vinson, J.A.; Oben, J.E.; Ngogang, J.Y. In Vitro Antioxidant Activity of Three Piper Species. J. Herb. Pharmacother. 2008, 7, 49–64. [Google Scholar] [CrossRef]
  117. Umadevi, P.; Deepti, K.; Venugopal, D.V.R. Synthesis, anticancer and antibacterial activities of piperine analogs. Med. Chem. Res. 2013, 22, 5466–5471. [Google Scholar] [CrossRef]
  118. Mgbeahuruike, E.E.; Fyhrquist, P.; Vuorela, H.; Julkunen-Tiitto, R.; Holm, Y. Alkaloid-Rich Crude Extracts, Fractions and Piperamide Alkaloids of Piper guineense Possess Promising Antibacterial Effects. Antibiotics 2018, 7, 98. [Google Scholar] [CrossRef] [Green Version]
  119. Philipova, I.; Valcheva, V.; Mihaylova, R.; Mateeva, M.; Doytchinova, I.; Stavrakov, G. Synthetic piperine amide analogs with antimycobacterial activity. Chem. Biol. Drug Des. 2017, 91, 763–768. [Google Scholar] [CrossRef]
  120. Mgbeahuruike, E.E.; Stålnacke, M.; Vuorela, H.; Holm, Y. Antimicrobial and Synergistic Effects of Commercial Piperine and Piperlongumine in Combination with Conventional Antimicrobials. Antibiotics 2019, 8, 55. [Google Scholar] [CrossRef] [Green Version]
  121. Kim, N.; Do, J.; Bae, J.; Jin, H.K.; Kim, J.-H.; Inn, K.-S.; Oh, M.S.; Lee, J.K. Piperlongumine Inhibits Neuroinflammation via Regulating NF-ΚB Signaling Pathways in Lipopolysaccharide-Stimulated BV2 Microglia Cells. J. Pharmacol. Sci. 2018, 137, 195–201. [Google Scholar] [CrossRef] [PubMed]
  122. Choudhary, N.; Singh, V. A Census of P. Longum’s Phytochemicals and Their Network Pharmacological Evaluation for Identifying Novel Drug-like Molecules against Various Diseases, with a Special Focus on Neurological Disorders. PLoS ONE 2018, 13, e0191006. [Google Scholar] [CrossRef] [PubMed]
  123. Osho, I.B.; Adebayo, I.A.; Ajayi, O.I. Immunological Evaluation of Antiviral Activity of Methanolic Extract of Piper Guineense against Newcastle Disease in Experimentally Infected Broiler Chickens. Int. J. Mol. Vet. Res. 2016, 6, 2. [Google Scholar] [CrossRef]
  124. Sharma, V.; Chaudhary, U. An Overview on Indigenous Knowledge of Achyranthes Aspera. J. Crit. Rev. 2015, 2, 7–19. [Google Scholar]
  125. Mukherjee, H.; Ojha, D.; Bag, P.; Chandel, H.S.; Bhattacharyya, S.; Chatterjee, T.K.; Mukherjee, P.K.; Chakraborti, S.; Chattopadhyay, D. Anti-herpes virus activities of Achyranthes aspera: An Indian ethnomedicine, and its triterpene acid. Microbiol. Res. 2013, 168, 238–244. [Google Scholar] [CrossRef]
  126. Ajibesin, K.; René, N.; Bala, D.; Essiett, U. Antimicrobial Activities of the Extracts and Fractions of Allanblackia floribunda. Biotechnol. 2008, 7, 129–133. [Google Scholar] [CrossRef] [Green Version]
  127. Edwin, S.; Jarald, E.E.; Deb, L.; Jain, A.; Kinger, H.; Dutt, K.; Raj, A.A. Wound Healing and Antioxidant Activity of Achyranthes aspera. Pharm. Biol. 2008, 46, 824–828. [Google Scholar] [CrossRef]
  128. Chakrabarti, R.; Srivastava, P.K.; Verma, N.; Sharma, J. Effect of seeds of Achyranthes aspera on the immune responses and expression of some immune-related genes in carp Catla catla. Fish Shellfish. Immunol. 2014, 41, 64–69. [Google Scholar] [CrossRef]
  129. Rao, A.; Balachandran, B. Role of Oxidative Stress and Antioxidants in Neurodegenerative Diseases. Nutr. Neurosci. 2002, 5, 291–309. [Google Scholar] [CrossRef]
  130. Abi Beaulah, G.; Mohamed Sadiq, A.; Jaya Santhi, R. Antioxidant and Antibacterial Activity of Achyranthes Aspera: An in Vitro Study. Ann. Biol. Res. 2011, 2, 662–670. [Google Scholar]
  131. Carr, A.C.; Maggini, S. Vitamin C and Immune Function. Nutrients 2017, 9, 1211. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  132. Chakraborty, A.; Brantner, A.; Mukainaka, T.; Nobukuni, Y.; Kuchide, M.; Konoshima, T.; Tokuda, H.; Nishino, H. Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis. Cancer Lett. 2002, 177, 1–5. [Google Scholar] [CrossRef] [PubMed]
  133. Arora, S.; Tandon, S. Achyranthes aspera Root Extracts Induce Human Colon Cancer Cell (COLO-205) Death by Triggering the Mitochondrial Apoptosis Pathway and S Phase Cell Cycle Arrest. Sci. World J. 2014, 2014, 129697. [Google Scholar] [CrossRef] [Green Version]
  134. Petrovska, B.B.; Cekovska, S. Extracts from the history and medical properties of garlic. Pharmacogn. Rev. 2010, 4, 106–110. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  135. Garcia, S. Pandemics and Traditional Plant-Based Remedies. A Historical-Botanical Review in the Era of COVID19. Front. Plant Sci. 2020, 11, 571042. [Google Scholar] [CrossRef]
  136. Otunola, A.G.; Asowata-Ayodele, A.M.; Afolayan, A.J. Assessment of the polyphenolic content, free radical scavenging, anti-inflammatory, and antimicrobial activities of acetone and aqueous extracts of Lippia javanica (Burm.F.) spreng. Pharmacogn. Mag. 2016, 12, 353–362. [Google Scholar] [CrossRef] [Green Version]
  137. Tijani, K.B.; Alfa, A.A.; Sezor, A.A. Studies on Phytochemical, Nutraceutical Profiles and Potential Medicinal Values of Allium sativum Linn (Lilliaceae) on Bacterial Meningitis. Int. Neuropsychiatr. Dis. J. 2019, 13, 1–15. [Google Scholar] [CrossRef] [Green Version]
  138. Sulaiman, F.A.; Kazeem, M.O.; Waheed, A.M.; Temowo, S.O.; Azeez, I.O.; Zubair, F.I.; Adeyemi, T.A.; Nyang, A.; Adeyemi, O.S. Antimicrobial and Toxic Potential of Aqueous Extracts of Allium Sativum, Hibiscus Sabdariffa and Zingiber Officinale in Wistar Rats. J. Taibah Univ. Sci. 2014, 8, 315–322. [Google Scholar] [CrossRef]
  139. Bayan, L.; Koulivand, P.H.; Gorji, A. Garlic: A review of potential therapeutic effects. Avicenna J. Phytomed. 2014, 4, 1–14. [Google Scholar] [CrossRef]
  140. Mphuthi, D.D.; Husaini, D.C. Traditional medicinal plants used by hypertensive patients in Belize: A qualitative evaluation of beliefs and practices. Bull. Natl. Res. Cent. 2022, 46, 107. [Google Scholar] [CrossRef]
  141. Colín-González, A.L.; Santana, R.A.; Silva-Islas, C.A.; Chánez-Cárdenas, M.E.; Santamaría, A.; Maldonado, P.D. The Antioxidant Mechanisms Underlying the Aged Garlic Extract- and S-Allylcysteine-Induced Protection. Oxidative Med. Cell. Longev. 2012, 2012, 907162. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  142. Aviello, G.; Abenavoli, L.; Borrelli, F.; Capasso, R.; Izzo, A.A.; Lembo, F.; Romano, B.; Capasso, F. Garlic: Empiricism or Science? Nat. Prod. Commun. 2009, 4, 1934578X0900401231. [Google Scholar] [CrossRef] [Green Version]
  143. Badal, D.S.; Dwivedi, A.K.; Kumar, V.; Singh, S.; Prakash, A.; Verma, S.; Kumar, J. Effect of Organic Manures and Inorganic Fertilizers on Growth, Yield and Its Attributing Traits in Garlic (Allium Sativum L.). J. Pharmacogn. Phytochem. 2019, 8, 587–590. [Google Scholar]
  144. Slusarenko, A.J.; Patel, A.; Portz, D. Control of plant diseases by natural products: Allicin from garlic as a case study. Eur. J. Plant Pathol. 2008, 121, 313–322. [Google Scholar] [CrossRef]
  145. Al-Snafi, A.E. Pharmacological Effects of Allium Species Grown in Iraq. An Overview. Int. J. Pharm. Health Care Res. 2013, 1, 132–147. [Google Scholar]
  146. Zeng, Y.; Li, Y.; Yang, J.; Pu, X.; Du, J.; Yang, X.; Yang, T.; Yang, S. Therapeutic Role of Functional Components in Alliums for Preventive Chronic Disease in Human Being. Evidence-Based Complement. Altern. Med. 2017, 2017, 7821095. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  147. El-Saber Batiha, G.; Magdy Beshbishy, A.; Wasef, G.L.; Elewa, Y.H.; Al-Sagan, A.A.; Abd El-Hack, M.E.; Taha, A.E.; Abd-Elhakim, Y.M.; Prasad Devkota, H. Chemical Constituents and Pharmacological Activities of Garlic (Allium Sativum L.): A Review. Nutrients 2020, 12, 872. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  148. Asdaq, S.M.B.; Inamdar, M.N. Pharmacodynamic and Pharmacokinetic Interactions of Propranolol with Garlic (Allium sativum) in Rats. Evidence-Based Complement. Altern. Med. 2011, 2011, 824042. [Google Scholar] [CrossRef] [Green Version]
  149. Wallock-Richards, D.; Doherty, C.J.; Doherty, L.; Clarke, D.J.; Place, M.; Govan, J.R.W.; Campopiano, D.J. Garlic Revisited: Antimicrobial Activity of Allicin-Containing Garlic Extracts against Burkholderia cepacia Complex. PLoS ONE 2014, 9, e112726. [Google Scholar] [CrossRef] [Green Version]
  150. Shokrzadeh, M.; Ebadi, A.G. Antibacterial Effect of Garlic (Allium Sativum L.) on Staphylococcus Aureus. Pak. J. Biol. Sci. 2006, 9, 1577–1579. [Google Scholar] [CrossRef]
  151. Jang, H.-J.; Lee, H.-J.; Yoon, D.-K.; Ji, D.-S.; Kim, J.-H.; Lee, C.-H. Antioxidant and antimicrobial activities of fresh garlic and aged garlic by-products extracted with different solvents. Food Sci. Biotechnol. 2017, 27, 219–225. [Google Scholar] [CrossRef] [PubMed]
  152. Abdel-Daim, M.M.; Shaheen, H.M.; Abushouk, A.I.; Toraih, E.A.; Fawzy, M.S.; Alansari, W.S.; Aleya, L.; Bungau, S. Thymoquinone and diallyl sulfide protect against fipronil-induced oxidative injury in rats. Environ. Sci. Pollut. Res. 2018, 25, 23909–23916. [Google Scholar] [CrossRef] [PubMed]
  153. Shang, A.; Cao, S.-Y.; Xu, X.-Y.; Gan, R.-Y.; Tang, G.-Y.; Corke, H.; Mavumengwana, V.; Li, H.-B. Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.). Foods 2019, 8, 246. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  154. Chen, Y.; Sun, J.; Dou, C.; Li, N.; Kang, F.; Wang, Y.; Cao, Z.; Yang, X.; Dong, S. Alliin Attenuated RANKL-Induced Osteoclastogenesis by Scavenging Reactive Oxygen Species through Inhibiting Nox1. Int. J. Mol. Sci. 2016, 17, 1516. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  155. Gruhlke, M.C.H.; Nicco, C.; Batteux, F.; Slusarenko, A.J. The Effects of Allicin, a Reactive Sulfur Species from Garlic, on a Selection of Mammalian Cell Lines. Antioxidants 2016, 6, 1. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  156. Ross, Z.M.; O’Gara, E.A.; Hill, D.J.; Sleightholme, H.V.; Maslin, D.J. Antimicrobial Properties of Garlic Oil against Human Enteric Bacteria: Evaluation of Methodologies and Comparisons with Garlic Oil Sulfides and Garlic Powder. Appl. Environ. Microbiol. 2001, 67, 475–480. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  157. Cutler, R.R.; Wilson, P. Antibacterial Activity of a New, Stable, Aqueous Extract of Allicin against Methicillin-Resistant Staphylococcus Aureus. Br. J. Biomed. Sci. 2004, 61, 71–74. [Google Scholar] [CrossRef] [PubMed]
  158. Kuda, T.; Iwai, A.; Yano, T. Effect of red pepper Capsicum annuum var. conoides and garlic Allium sativum on plasma lipid levels and cecal microflora in mice fed beef tallow. Food Chem. Toxicol. 2004, 42, 1695–1700. [Google Scholar] [CrossRef]
  159. Kumar, P.; Yadav, J.; Jain, M.; Yadav, P.; Goel, A.; Yadava, P.K. Bactericidal Efficacy of Allium sativum (garlic) Against Multidrug Resistant Vibrio cholerae O1 Epidemic Strains. Def. Sci. J. 2016, 66, 479–484. [Google Scholar] [CrossRef] [Green Version]
  160. Razis, A.F.A.; Ibrahim, M.D.; Kntayya, S.B. Health Benefits of Moringa oleifera. Asian Pac. J. Cancer Prev. 2014, 15, 8571–8576. [Google Scholar] [CrossRef]
  161. Leone, A.; Spada, A.; Battezzati, A.; Schiraldi, A.; Aristil, J.; Bertoli, S. Cultivation, Genetic, Ethnopharmacology, Phytochemistry and Pharmacology of Moringa oleifera Leaves: An Overview. Int. J. Mol. Sci. 2015, 16, 12791–12835. [Google Scholar] [CrossRef]
  162. Dhakad, A.K.; Ikram, M.; Sharma, S.; Khan, S.; Pandey, V.V.; Singh, A. Biological, Nutritional, and Therapeutic Significance of Moringa Oleifera Lam. Phytother. Res. 2019, 33, 2870–2903. [Google Scholar] [CrossRef] [PubMed]
  163. Mashamaite, C.V.; Pieterse, P.J.; Mothapo, P.N.; Phiri, E.E. Moringa oleifera in South Africa: A review on its production, growing conditions and consumption as a food source. S. Afr. J. Sci. 2021, 117, 1–7. [Google Scholar] [CrossRef] [PubMed]
  164. Nouman, W.; Siddiqui, M.T.; BASRA, S.; AHMED, M.; FAROOQ, H.; ZUBAIR, M.; GULL, T. Biomass Production and Nutritional Quality of Moringa Oleifera as a Field Crop. Turk. J. Agric. For. 2013, 37, 410–419. [Google Scholar] [CrossRef]
  165. El-Hak, H.N.; Moustafa, A.R.A.; Mansour, S.R. Toxic effect of Moringa peregrina seeds on histological and biochemical analyses of adult male Albino rats. Toxicol. Rep. 2017, 5, 38–45. [Google Scholar] [CrossRef] [PubMed]
  166. Kasolo, J.N.; Bimenya, G.S.; Ojok, L.; Ochieng, J.; Ogwal-Okeng, J.W. Phytochemicals and Uses of Moringa Oleifera Leaves in Ugandan Rural Communities. J. Med. Plant Res. 2010, 4, 753–757. [Google Scholar] [CrossRef]
  167. Popoola, J.O.; Obembe, O.O. Local knowledge, use pattern and geographical distribution of Moringa oleifera Lam. (Moringaceae) in Nigeria. J. Ethnopharmacol. 2013, 150, 682–691. [Google Scholar] [CrossRef]
  168. Biswas, D.; Nandy, S.; Mukherjee, A.; Pandey, D.; Dey, A. Moringa oleifera Lam. and derived phytochemicals as promising antiviral agents: A review. S. Afr. J. Bot. 2019, 129, 272–282. [Google Scholar] [CrossRef]
  169. Xiong, Y.; Rajoka, M.S.R.; Mehwish, H.M.; Zhang, M.; Liang, N.; Li, C.; He, Z. Virucidal activity of Moringa A from Moringa oleifera seeds against Influenza A Viruses by regulating TFEB. Int. Immunopharmacol. 2021, 95, 107561. [Google Scholar] [CrossRef]
  170. Otunola, G.A.; Afolayan, A.J. Antidiabetic Effect of Combined Spices of Allium Sativum, Zingiber Officinale and Capsicum Frutescens in Alloxan-Induced Diabetic Rats. Front. Life Sci. 2015, 8, 314–323. [Google Scholar] [CrossRef]
  171. Ravindran, P.N.; Babu, K.N. Ginger: The Genus Zingiber; CRC press: Boca Raton, FL, USA, 2016. [Google Scholar]
  172. Sowley, E.N.K.; Kankam, F. Harnessing the Therapeutic Properties of Ginger (Zingiber officinale Roscoe) for the Management of Plant Diseases. In Ginger Cultivation and Its Antimicrobial and Pharmacological Potentials; IntechOpen: London, UK, 2019. [Google Scholar] [CrossRef]
  173. Dhanik, J.; Arya, N.; Nand, V. A Review on Zingiber Officinale. J. Pharmacogn. Phytochem. 2017, 6, 174–184. [Google Scholar]
  174. Taoheed, A.A.; Tolulope, A.A.; Saidu, A.B.; Odewumi, O.G.; Sunday, R.M.; Usman, M. Phytochemical Properties, Proximate and Mineral Composition of Curcuma longa Linn. and Zingiber officinale Rosc.: A Comparative Study. J. Sci. Res. Rep. 2017, 13, 1–7. [Google Scholar] [CrossRef]
  175. Sombie, E.N.; Tibiri, A.; N’Do, J.Y.-P.; Traore, T.K.; Ouedraogo, N.; Hilou, A.; Guissou, P.I.; Nacoulma, O.G. Ethnobotanical study and antioxidant activity of anti-hepatitis plants extracts of the COMOE province, Burkina Faso. Int. J. Biol. Chem. Sci. 2018, 12, 1308. [Google Scholar] [CrossRef]
  176. Mao, Q.-Q.; Xu, X.-Y.; Cao, S.-Y.; Gan, R.-Y.; Corke, H.; Beta, T.; Li, H.-B. Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe). Foods 2019, 8, 185. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  177. Kumar, N.V.; Murthy, P.S.; Manjunatha, J.; Bettadaiah, B. Synthesis and quorum sensing inhibitory activity of key phenolic compounds of ginger and their derivatives. Food Chem. 2014, 159, 451–457. [Google Scholar] [CrossRef] [PubMed]
  178. Zhang, M.; Viennois, E.; Prasad, M.; Zhang, Y.; Wang, L.; Zhang, Z.; Han, M.K.; Xiao, B.; Xu, C.; Srinivasan, S.; et al. Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials 2016, 101, 321–340. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  179. Suekawa, M.; Ishige, A.; Yuasa, K.; Sudo, K.; Aburada, M.; Hosoya, E. Pharmacological studies on Ginger. I. Pharmacological actions of pungent constituents, (6)-gingerol and (6)-shogaol. J. Pharmacobio-Dyn. 1984, 7, 836–848. [Google Scholar] [CrossRef]
  180. Mbadiko, C.M.; Inkoto, C.L.; Gbolo, B.Z.; Lengbiye, E.M.; Kilembe, J.T.; Matondo, A.; Mwanangombo, D.T.; Ngoyi, E.M.; Bongo, G.N.; Falanga, C.M.; et al. A Mini Review on the Phytochemistry, Toxicology and Antiviral Activity of Some Medically Interesting Zingiberaceae Species. J. Complement. Altern. Med Res. 2020, 9, 44–56. [Google Scholar] [CrossRef]
  181. Chang, J.S.; Wang, K.C.; Yeh, C.F.; Shieh, D.E.; Chiang, L.C. Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. J. Ethnopharmacol. 2013, 145, 146–151. [Google Scholar] [CrossRef]
  182. Rathinavel, T.; Palanisamy, M.; Srinivasan, P.; Subramanian, A.; Thangaswamy, S. Phytochemical 6-Gingerol -A promising Drug of choice for COVID-19. Int. J. Adv. Sci. Eng. 2020, 6, 1482–1489. [Google Scholar] [CrossRef]
  183. Kabuto, H.; Nishizawa, M.; Tada, M.; Higashio, C.; Shishibori, T.; Kohno, M. Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] Prevents 6-Hydroxydopamine-induced Dopamine Depression in Mouse Striatum and Increases Superoxide Scavenging Activity in Serum. Neurochem. Res. 2005, 30, 325–332. [Google Scholar] [CrossRef]
  184. Asnani, V.; Verma, R.J. Antioxidative Effect of Rhizome of Zingiber Officinale on Paraben Induced Lipid Peroxidation: An in Vitro Study. Acta Pol. Pharm. 2007, 64, 35–37. [Google Scholar] [PubMed]
  185. Kim, J.-K.; Kim, Y.; Na, K.-M.; Surh, Y.-J.; Kim, T.-Y. (6)-Gingerol Prevents UVB-Induced ROS Production and COX-2 Expression in Vitro and in Vivo. Free Radic. Res. 2007, 41, 603–614. [Google Scholar] [CrossRef] [PubMed]
  186. Liu, Y.; Whelan, R.; Pattnaik, B.; Ludwig, K.; Subudhi, E.; Rowland, H.; Claussen, N.; Zucker, N.; Uppal, S.; Kushner, D.M.; et al. Terpenoids from Zingiber officinale (Ginger) Induce Apoptosis in Endometrial Cancer Cells through the Activation of p53. PLoS ONE 2012, 7, e53178. [Google Scholar] [CrossRef] [Green Version]
  187. Brahmbhatt, M.; Gundala, S.R.; Asif, G.; Shamsi, A.S.; Aneja, R. Ginger Phytochemicals Exhibit Synergy to Inhibit Prostate Cancer Cell Proliferation. Nutr. Cancer 2013, 65, 263–272. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  188. Jiang, Y.; Turgeon, D.K.; Wright, B.D.; Sidahmed, E.; Ruffin, M.T.; Brenner, D.E.; Sen, A.; Zick, S.M. Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer. Eur. J. Cancer Prev. 2013, 22, 455–460. [Google Scholar] [CrossRef]
  189. Ling, H.; Yang, H.; Tan, S.-H.; Chui, W.-K.; Chew, E.-H. 6-Shogaol, an Active Constituent of Ginger, Inhibits Breast Cancer Cell Invasion by Reducing Matrix Metalloproteinase-9 Expression via Blockade of Nuclear Factor-ΚB Activation. Br. J. Pharmacol. 2010, 161, 1763–1777. [Google Scholar] [CrossRef] [Green Version]
  190. Kim, E.-C.; Min, J.-K.; Kim, T.-Y.; Lee, S.-J.; Yang, H.-O.; Han, S.; Kim, Y.-M.; Kwon, Y.-G. (6)-Gingerol, a Pungent Ingredient of Ginger, Inhibits Angiogenesis in Vitro and in Vivo. Biochem. Biophys. Res. Commun. 2005, 335, 300–308. [Google Scholar] [CrossRef]
  191. Flynn, D.L.; Rafferty, M.F.; Boctor, A.M. Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: Inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot. Med. 1986, 22, 357–360. [Google Scholar] [CrossRef]
  192. Kiuchi, F.; Iwakami, S.; Shibuya, M.; Hanaoka, F.; Sankawa, U. Inhibition of Prostaglandin and Leukotriene Biosynthesis by Gingerols and Diarylheptanoids. Chem. Pharm. Bull. 1992, 40, 387–391. [Google Scholar] [CrossRef]
  193. Beloin, N.; Gbeassor, M.; Akpagana, K.; Hudson, J.; de Soussa, K.; Koumaglo, K.; Arnason, J.T. Ethnomedicinal Uses of Momordica Charantia (Cucurbitaceae) in Togo and Relation to Its Phytochemistry and Biological Activity. J. Ethnopharmacol. 2005, 96, 49–55. [Google Scholar] [CrossRef] [PubMed]
  194. Bakare, R.I.; Magbagbeola, O.A.; Akinwande, A.I.; Okunowo, O.W. Nutritional and Chemical Evaluation of Momordica Charantia. J. Med. Plants Res. 2010, 4, 2189–2193. [Google Scholar]
  195. Joseph, B.; Jini, D. Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac. J. Trop. Dis. 2013, 3, 93–102. [Google Scholar] [CrossRef]
  196. Jia, S.; Shen, M.; Zhang, F.; Xie, J. Recent Advances in Momordica charantia: Functional Components and Biological Activities. Int. J. Mol. Sci. 2017, 18, 2555. [Google Scholar] [CrossRef] [Green Version]
  197. Bourinbaiar, A.S.; Lee-Huang, S. The Activity of Plant-Derived Antiretroviral Proteins MAP30 and GAP31 against Herpes Simplex Virus Infectionin Vitro. Biochem. Biophys. Res. Commun. 1996, 219, 923–929. [Google Scholar] [CrossRef]
  198. Rebultan, S.P. Bitter melon therapy: An experimental treatment of HIV infection. Aids Asia Voice Asian Solidar. Against AIDS 1995, 2, 6–7. [Google Scholar]
  199. Raina, K.; Kumar, D.; Agarwal, R. Promise of bitter melon ( Momordica charantia ) bioactives in cancer prevention and therapy. Semin. Cancer Biol. 2016, 40–41, 116–129. [Google Scholar] [CrossRef] [Green Version]
  200. Ray, R.B.; Raychoudhuri, A.; Steele, R.; Nerurkar, P. Bitter Melon (Momordica Charantia) Extract Inhibits Breast Cancer Cell Proliferation by Modulating Cell Cycle Regulatory Genes and Promotes ApoptosisBitter Melon Extract Inhibits Breast Cancer Cell Growth. Cancer Res. 2010, 70, 1925–1931. [Google Scholar]
  201. Kwatra, D.; Subramaniam, D.; Ramamoorthy, P.; Standing, D.; Moran, E.; Velayutham, R.; Mitra, A.; Umar, S.; Anant, S. Methanolic Extracts of Bitter Melon Inhibit Colon Cancer Stem Cells by Affecting Energy Homeostasis and Autophagy. Evidence-Based Complement. Altern. Med. 2013, 2013, 702869. [Google Scholar] [CrossRef] [Green Version]
  202. Fang, E.F.; Froetscher, L.; Scheibye-Knudsen, M.; Bohr, V.A.; Wong, J.H.; Ng, T.B. Emerging Antitumor Activities of the Bitter Melon (Momordica charantia). Curr. Protein Pept. Sci. 2019, 20, 296–301. [Google Scholar] [CrossRef]
  203. Akinpelu, C.A.; Adebayo, O.S.; Adewale, O.M.; Adebisi-Adelani, O.O. An Analysis of Turmeric Utilisation Pattern in Ekiti State, Nigeria. Niger. J. Horticult. Sci. 2012, 17, 68–72. [Google Scholar]
  204. Mahomoodally, M.F. Traditional Medicines in Africa: An Appraisal of Ten Potent African Medicinal Plants. Evid.-Based Complement. Altern. Med. 2013, 2013, 617459. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  205. Nwaekpe, J.O.; Anyaegbunam, H.N.; Okoye, B.C.; Asumugha, G.N. Promotion of Turmeric for the Food/Pharmaceutical Industry in Nigeria. Am. J. Exp. Agric. 2015, 8, 335–341. [Google Scholar] [CrossRef]
  206. Omosa, L.K.; Midiwo, J.O.; Kuete, V. Curcuma Longa. In Medicinal Spices and Vegetables from Africa; Elsevier: Amsterdam, The Netherlands, 2017; pp. 425–435. [Google Scholar] [CrossRef]
  207. Iwu, M.M. African Medicinal Plants; CRC Press: College Park, MD, USA, 1993. [Google Scholar]
  208. Aggarwal, M.L.; Chacko, K.M.; Kuruvilla, B.T. Systematic and comprehensive investigation of the toxicity of curcuminoid-essential oil complex: A bioavailable turmeric formulation. Mol. Med. Rep. 2015, 13, 592–604. [Google Scholar] [CrossRef] [Green Version]
  209. Uchejeso, O.M.; Chinaza, I.R.; Goodluck, O.A.; Rinpan, J.I. Some Igbo Indigenous Plants with Anti-COVID-19 Properties. In Alternative Medicine-Update; IntechOpen: London, UK, 2020. [Google Scholar] [CrossRef]
  210. Nwokocha, C.R.; Ozolua, I.R.; Owu, D.U.; Nwokocha, I.M.; Ugwu, A.C. Antihypertensive properties of Allium sativum (garlic) on normotensive and two kidney one clip hypertensive rats. Niger. J. Physiol. Sci. 2011, 26, 213–218. [Google Scholar]
  211. Voidarou, C.; Antoniadou, Μ.; Rozos, G.; Tzora, A.; Skoufos, I.; Varzakas, T.; Lagiou, A.; Bezirtzoglou, E. Fermentative Foods: Microbiology, Biochemistry, Potential Human Health Benefits and Public Health Issues. Foods 2021, 10, 69. [Google Scholar] [CrossRef]
  212. Valdes, A.; Walter, J.; Segal, E.; Spector, T.D. Role of the gut microbiota in nutrition and health. BMJ 2018, 361, k2179. [Google Scholar] [CrossRef] [Green Version]
  213. Plaza-Diaz, J.; Ruiz-Ojeda, F.J.; Gil-Campos, M.; Gil, A. Mechanisms of Action of Probiotics. Adv. Nutr. 2019, 10 (Suppl. 1), S49–S66. [Google Scholar] [CrossRef] [Green Version]
  214. Yeşilyurt, N.; Yılmaz, B.; Ağagündüz, D.; Capasso, R. Involvement of Probiotics and Postbiotics in the Immune System Modulation. Biologics 2021, 1, 89–110. [Google Scholar] [CrossRef]
  215. Liu, Y.; Tran, D.Q.; Rhoads, J.M. Probiotics in Disease Prevention and Treatment. J. Clin. Pharmacol. 2018, 58 (Suppl. 10), S164–S179. [Google Scholar] [CrossRef] [Green Version]
  216. Mahooti, M.; Miri, S.M.; Abdolalipour, E.; Ghaemi, A. The Immunomodulatory Effects of Probiotics on Respiratory Viral Infections: A Hint for COVID-19 Treatment? Microb. Pathog. 2020, 148, 104452. [Google Scholar] [CrossRef] [PubMed]
  217. Mirashrafi, S.; Moravejolahkami, A.R.; Zehi, Z.B.; Kermani, M.A.H.; Bahreini-Esfahani, N.; Haratian, M.; Dashti, M.G.; Pourhossein, M. The efficacy of probiotics on virus titres and antibody production in virus diseases: A systematic review on recent evidence for COVID-19 treatment. Clin. Nutr. ESPEN 2021, 46, 1–8. [Google Scholar] [CrossRef] [PubMed]
  218. Janssen, R.; Visser, M.P.J.; Dofferhoff, A.S.M.; Vermeer, C.; Janssens, W.; Walk, J. Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in Coronavirus disease 2019. Br. J. Nutr. 2021, 126, 191–198. [Google Scholar] [CrossRef] [PubMed]
  219. Linneberg, A.; Kampmann, F.; Israelsen, S.; Andersen, L.; Jørgensen, H.; Sandholt, H.; Jørgensen, N.; Thysen, S.; Benfield, T. The Association of Low Vitamin K Status with Mortality in a Cohort of 138 Hospitalized Patients with COVID-19. Nutrients 2021, 13, 1985. [Google Scholar] [CrossRef] [PubMed]
  220. Walther, B.; Chollet, M. Menaquinones, Bacteria, and Foods: Vitamin K2 in the Diet. In Vitamin K2-Vital for Health and Wellbeing; Gordeladze, J.O., Ed.; IntechOpen: London, UK, 2017. [Google Scholar] [CrossRef] [Green Version]
  221. De Filippis, F.; Parente, E.; Ercolini, D. Metagenomics insights into food fermentations. Microb. Biotechnol. 2016, 10, 91–102. [Google Scholar] [CrossRef]
  222. Sofowora, A. The present status of knowledge of the plants used in traditional medicine in western Africa: A medical approach and a chemical evaluation. J. Ethnopharmacol. 1980, 2, 109–118. [Google Scholar] [CrossRef]
  223. Husaini, D.C.; Orisakwe, O.E.; Mphuthi, D.D.; Garba, S.M.; Obasi, C.N.; Nwachukwu, I.E. Phytotherapies for COVID-19 in Latin America and the Caribbean (LAC): Implications for present and future pandemics. Arab Gulf J. Sci. Res. 2023. ahead of print. [Google Scholar] [CrossRef]
  224. Moeti, M.; Cabore, J.; Kasolo, F.; Yoti, Z.; Zawaira, F.; Chibi, F.Z.M.; Rajatonirina, S.; Karamagi, H.; Rees, H.; Mihigo, R.; et al. The COVID-19 pandemic: Research and health development in the World Health Organisation Africa region. Pan Afr. Med. J. 2020, 35 (Supp. 2), 1–3. [Google Scholar] [CrossRef]
  225. Orisakwe, O.E.; Orish, C.N.; Nwanaforo, E.O. Coronavirus disease (COVID-19) and Africa: Acclaimed home remedies. Sci. Afr. 2020, 10, e00620. [Google Scholar] [CrossRef]
  226. Attah, A.F.; Fagbemi, A.A.; Olubiyi, O.; Dada-Adegbola, H.; Oluwadotun, A.; Elujoba, A.; Babalola, C.P. Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine with COVID-19 in Focus: A Nigerian Perspective. Front. Pharmacol. 2021, 12, 596855. [Google Scholar] [CrossRef]
  227. Galanakis, C.M. The Food Systems in the Era of the Coronavirus (COVID-19) Pandemic Crisis. Foods 2020, 9, 523. [Google Scholar] [CrossRef] [Green Version]
  228. Luo, H.; Tang, Q.-L.; Shang, Y.-X.; Liang, S.-B.; Yang, M.; Robinson, N.; Liu, J.-P. Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs. Chin. J. Integr. Med. 2020, 26, 243–250. [Google Scholar] [CrossRef]
  229. Im, K.; Kim, J.; Min, H. Ginseng, the natural effectual antiviral: Protective effects of Korean Red Ginseng against viral infection. J. Ginseng Res. 2016, 40, 309–314. [Google Scholar] [CrossRef] [Green Version]
  230. Kolodziej, H. Antimicrobial, Antiviral and Immunomodulatory Activity Studies of Pelargonium sidoides (EPs® 7630) in the Context of Health Promotion. Pharmaceuticals 2011, 4, 1295–1314. [Google Scholar] [CrossRef] [Green Version]
  231. Yang, Y.; Islam, M.S.; Wang, J.; Li, Y.; Chen, X. Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective. Int. J. Biol. Sci. 2020, 16, 1708–1717. [Google Scholar] [CrossRef]
  232. Ang, L.; Lee, H.W.; Choi, J.Y.; Zhang, J.; Lee, M.S. Herbal medicine and pattern identification for treating COVID-19: A rapid review of guidelines. Integr. Med. Res. 2020, 9, 100407. [Google Scholar] [CrossRef]
  233. Barrea, L.; Muscogiuri, G.; Frias-Toral, E.; Laudisio, D.; Pugliese, G.; Castellucci, B.; Garcia-Velasquez, E.; Savastano, S.; Colao, A. Nutrition and immune system: From the Mediterranean diet to dietary supplementary through the microbiota. Crit. Rev. Food Sci. Nutr. 2020, 61, 3066–3090. [Google Scholar] [CrossRef]
  234. Greene, M.W.; Roberts, A.P.; Frugé, A.D. Negative Association Between Mediterranean Diet Adherence and COVID-19 Cases and Related Deaths in Spain and 23 OECD Countries: An Ecological Study. Front. Nutr. 2021, 8, 591964. [Google Scholar] [CrossRef]
  235. Onder, G.; Rezza, G.; Brusaferro, S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA 2020, 323, 1775–1776. [Google Scholar] [CrossRef]
  236. Singh, A.K.; Gillies, C.L.; Singh, R.; Singh, A.; Chudasama, Y.; Coles, B.; Seidu, S.; Zaccardi, F.; Davies, M.J.; Khunti, K. Prevalence of co-morbidities and their association with mortality in patients with COVID -19: A systematic review and meta-analysis. Diabetes Obes. Metab. 2020, 22, 1915–1924. [Google Scholar] [CrossRef]
  237. Richardson, S.; Hirsch, J.S.; Narasimhan, M.; Crawford, J.M.; McGinn, T.; Davidson, K.W.; The Northwell COVID-19 Research Consortium. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized with COVID-19 in the New York City Area. JAMA 2020, 323, 2052–2059. [Google Scholar] [CrossRef]
  238. Xu, D.-P.; Li, Y.; Meng, X.; Zhou, T.; Zhou, Y.; Zheng, J.; Zhang, J.-J.; Li, H.-B. Natural Antioxidants in Foods and Medicinal Plants: Extraction, Assessment and Resources. Int. J. Mol. Sci. 2017, 18, 96. [Google Scholar] [CrossRef]
  239. Yu, M.; Gouvinhas, I.; Rocha, J.; Barros, A.I.R.N.A. Phytochemical and antioxidant analysis of medicinal and food plants towards bioactive food and pharmaceutical resources. Sci. Rep. 2021, 11, 10041. [Google Scholar] [CrossRef]
  240. Fotsing Yannick Stéphane, F.; Kezetas Jean Jules, B.; El-Saber Batiha, G.; Ali, I.; Ndjakou Bruno, L. Extraction of Bioactive Compounds from Medicinal Plants and Herbs. In Natural Medicinal Plants; A. El-Shemy, H., Ed.; IntechOpen: London, UK, 2022. [Google Scholar] [CrossRef]
  241. Akbarian, M.; Khani, A.; Eghbalpour, S.; Uversky, V.N. Bioactive Peptides: Synthesis, Sources, Applications, and Proposed Mechanisms of Action. Int. J. Mol. Sci. 2022, 23, 1445. [Google Scholar] [CrossRef]
Figure 1. Graphical illustration of the main health effects from African traditional fermented foods.
Figure 1. Graphical illustration of the main health effects from African traditional fermented foods.
Nutrients 15 00273 g001
Figure 2. Graphical illustration of main health effects from traditional herbal remedies.
Figure 2. Graphical illustration of main health effects from traditional herbal remedies.
Nutrients 15 00273 g002
Table 1. Traditional African fermented foods with potential health benefits, including the strength of the immune system.
Table 1. Traditional African fermented foods with potential health benefits, including the strength of the immune system.
Fermented FoodsRaw Food MaterialsMicro-OrganismsBioactive
Compounds
Potential Health
Benefits
References
Cereal-based fermented
foods
Maize (Zea mays), Sorghum (Sorghum bicolor),
Millet (Peninsetum americanum),
Acha or Fonio (Digitaria exilis),
Cassava (Manihot esculenta)
Bacteria (Lactobacillus, Lactococcus, Leuconostoc Pedicoccus genera)
Yeasts (Saccharomyces, Rhodotorula, Candida, Kluyveromyces, and Geotrichum genera)
Filamentous molds (Aspergillus, Rhizopus, Fusarium, and Penicillium, genera)
Soluble non-starch polysaccharides (e.g., arabinoxylan and β–glucan)
Nondigestible carbohydrates (e.g., galacto- and fructo–oligosaccharides)
Folates
Promote rich nondigestible carbohydrates (prebiotics),
increase in phenolic compounds, gamma-aminobutyric acid (GABA), and bioactive peptides contents.
Increase folates,
decrease mycotoxins levels, increase health benefits of probiotic consumption, reduce exposure to a variety of other chemical food contaminants and detoxification
[8,17,18,29,
33,35,36]
Meat- and fish-based fermented foodsMeat,
Fish
Bacteria
(Leuconostoc, Lactobacillus,
Enterococcus
Aerococcus, Bacillus genera)
Yeasts (Pichia, Candida, Hanseniaspora, Kluyveromyces Torulaspora, and Kluyveromyces genera)
Bioactive
peptides,
Bacteriocins
Antioxidant activity, increase health benefits of probiotic consumption, reduction of microbiological hazards[11,38,45,
52,59]
Dairy fermented products (fermented milk and cheeses)MilkBacteria
(Lactococcus Leuconostoc Streptococcus, Lactobacillus, Pediococcus genera)
Yeasts (Saccharomyces, Candida,
Kluyveromyces genera)
Bioactive peptides,
Conjugated Linoleic Acid,
Vitamin B12, Vitamin K2
Bacteriocins
Antioxidant, immunomodulatory,
source of vitamin B12 and vitamin K2,
increase health benefits of probiotic consumption, protection against food-spoilage
[11,38,61,65
68]
Table 2. African herbs/medicinal plants with immune-boosting and antiviral potentials.
Table 2. African herbs/medicinal plants with immune-boosting and antiviral potentials.
Herbs/
Medicinal Plants
Traditional UsesBioactive SubstancesPharmacologic ActivityImmunologic ActivityAntiviral ActivityReferences
Garcinia kola Heckel (Fam. Clusiaceae)
[Bitter cola]
Typhoid fever, bronchitis, bacterial infections, malignant tumors, skin infections, tuberculosis, gastritis, cold, jaundiceAlkaloids, phenols, saponins, sterols, tannins, garciniflavanone, kolanone, garcinoic acid, kolaflavanone, and kolavironAntiviral, antiasthma, antioxidant, antidiabetic, antihypertensive, antibacterial, antiasthma, and for hepatoprotective activitiesAntioxidant, hepatoprotective,
immunomodulatory, metal chelating, potent radical scavenger,
modulate oxidative stress
Polioviruses, measles virus, yellow fever virus, influenza, herpes simplex Virus-1, HIV[85,86,93,94,97,99,201]
Artemisia Afra Jacq. (Fam. Asteraceae)Influenza, respiratory infections, cough, malaria, diabetes, and feverDihydroxybishopsolicepolide, scopoletin, acacetin, flavonoids, yomogiarteminCytotoxic, anticancer, antiviralAntioxidant, anti-inflammatoryInfluenza virus A, human herpes viruses 1 and 2, Hepatitis B and C, HIV-1 viruses[103,104,105,106,109,110,113]
Piper guineense (Fam. Piperaceae) [African black pepper]Sexually transmitted diseasesPiperine, piperlongumine, ligans, monoterpenes, terpenoids, sterols, sesquiterpenes, and volatile oilsAntibacterial, anticancer, antiviral, antiproliferative, antifungal, antihelminthAntioxidant, anti-inflammatoryNewcastle disease virus[103,114,120,122]
Achyranthes Aspera Linn. (Fam. Amaranthaceae)Dysentery, arthritis, malaria, hemorrhoids, fever, pain, and diarrheaTriacontanol, eugenol, ecdysterone, betaine, ascorbic acidDiuretic, anti-inflammatory, anti-asthmatic, and valuable for pneumoniaAntioxidant, immune boosting, chemopreventativeHerpes simplex virus type 1 (HSV-1, oral herpes) and type 2 (HSV-2, genital herpes).
[92,124,125,126]
Allium sativum L. (Fam. Liliaceae)
[Garlic]
Influenza, typhus, cholera, dysentery, toothaches, snake bites, arthritis, and hypertensionPhenols, flavonoids, saponins, allicin (thiosulfate), diallyl trisulfate, ajoenes, diallyl disulfideAnticancer, antimicrobial, flu, diabetes, hypertension, arthritis, and for the prevention of cancerAntioxidants, immune boosterVesicular stomatitis virus, Human rhinovirus type 2, influenza virus type 3, human cytomegalovirus, influenza B type virus, and herpes simplex 1 and 2[134,142,143,147,155,210]
Moringa oleifera Lam. (Fam. Moringaceae)Food, livestock feed, nutrition, medicinesisothiocyanate, phenolic acids, polyphenols, sterols, alkaloids, terpene, flavonoids, and flavanol glycosidesAnti-parasitic, antituberculosis anticancer, antiviral, antidiabetic, sexually transmitted infections, typhoid fever, antihypertensiveAnti-inflammatory, cardio-protective, neuro-protective, hepato-protectiveInfluenza A virus, new castle disease virus, herpes simplex virus, Epstein-Barr virus, hepatitis B virus, and foot-and-mouth disease virus in cloven-footed animals[160,161,162,163,168,210]
Zingiber officinale R. (Fam Zingiberaceae)
[Ginger]
Influenza, cough, sore throats, arthritis, lung diseases, peptic ulcer disease, hypertension, infectious diseasesSteroids, phenols, alkaloids, gingerols, zingerone, zingiberol, paradols, and shogaolsAntiarthritic, anticancer, antioxidant, antirhinoviral, antimicrobial, antiglycemicAntioxidant, anti-inflammatoryEnterovirus 71, Japanese encephalitis virus, Epstein-Barr virus, herpes simplex virus types 1 and 2, influenza A virus, human immunodeficiency viruses, coronavirus SARS-CoV-1, rhinovirus, chikungunya virus, respiratory syncytial virus[92,173,174,175,176,177,178,182,186]
Momordica charantia (Fam. Cucurbitaceae) [Bitter melon]Diabetes, treat viral infections, toothache, diarrhea, gastrointestinal infections, ritual purposesMinerals, vitamins, phenol compounds, triterpene, lipid, protein, glycosides, steroids, saponins, flavonoidsAntiviral, recurrent respiratory tract infections, anthelmintic, anticancer, antidiabetic, abortifacient, contraceptiveAntioxidantHSV-1 and SINV viruses, HIV-1[194,195,196,
198]
Curcuma longa L. (Fam. Zingiberaceae) [Tumeric] Conjunctivitis, smallpox, sinusitisCurcuminoids, Quercetin, Cuscumin, zingiberine, borneol, alpha phellandreneAntioxidant, anticancer, immunomodulatory, antimicrobial, antiviralAntioxidant, immune modulatorHIV-1, H1N1, hepatitis C, parainfluenza virus type-3, H6N1, human papillomavirus, and coxsackievirus B3[205,206,207,
209]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Frazzoli, C.; Grasso, G.; Husaini, D.C.; Ajibo, D.N.; Orish, F.C.; Orisakwe, O.E. Immune System and Epidemics: The Role of African Indigenous Bioactive Substances. Nutrients 2023, 15, 273. https://doi.org/10.3390/nu15020273

AMA Style

Frazzoli C, Grasso G, Husaini DC, Ajibo DN, Orish FC, Orisakwe OE. Immune System and Epidemics: The Role of African Indigenous Bioactive Substances. Nutrients. 2023; 15(2):273. https://doi.org/10.3390/nu15020273

Chicago/Turabian Style

Frazzoli, Chiara, Gerardo Grasso, Danladi Chiroma Husaini, Doris Nnenna Ajibo, Fortune Chiemelie Orish, and Orish E. Orisakwe. 2023. "Immune System and Epidemics: The Role of African Indigenous Bioactive Substances" Nutrients 15, no. 2: 273. https://doi.org/10.3390/nu15020273

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop